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SUMMARY
Prolonged, excessive consumption of alcohol 
results in a disease of the heart muscle termed 'alcoholic 
cardiomyopathy'. Since the heart muscle does not contain 
alcohol dehydrogenase, the toxicity of alcohol is due to 
a direct toxic effect of ethanol on the myocardium and/or 
secondary metabolic disorders which, result from oxidation 
of ethanol in the liver.
At the metabolic level, the effects of alcohol 
include the depression of mitochondrial function, includ­
ing respiration and calcium sequestration, inhibition of 
key enzymes of the tricarboxylic acid cycle and impaired 
fatty acid oxidation. These changes are illustrated by 
pronounced ultrastructural changes in the myocardium shown 
by electron microscopy. The ultrastructural changes 
include degenerate mitochondria, accumulation of triglycer­
ide droplets, swollen elements of the sarcoplasmic 
reticulum, and myofiber degeneration. The primary clinical 
feature of alcoholic cardiomyopathy is loss of cardiac 
contractility. This may eventuate in congestive heart 
f ailure.
The exact nature and sequence of metabolic and 
ultrastructural changes which lead to myocardial failure 
are not clear. In an attempt to evaluate the effect of 
ethanol on 1) mitochondrial respiratory function; 2) fatty 
acid oxidation; 3) cardiac ultrastructure; and 4) mito­
chondrial protein composition, rats were chronically fed 
ethanol for 60 and 120 days. The ethanol provided 40% of 
their daily total caloric intake and was administered in a
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25% aqueous ethanol solution as the sole source of drinking 
fluid.
The results obtained indicated that chronic con­
sumption of moderate amounts of ethanol are capable of 
affecting several enzymes of fatty acid oxidation. In 
addition, the profile of the products of mitochondrial 
protein synthesis showed a significant change after 120 
days of ethanol treatment. Mitochondrial respiration and 
cardiac ultrastructure were not significantly altered by 
ethanol treatment during this time course.
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ABBREVIATIONS AND NOMENCLATURE
Abbreviations in the text, tables and figures conform 
wherever possible to those of the Biochemical Journal.
In addition, the following abbreviations have been used.
BSA Bovine serum albumin
Butyl-PBD 2(4'-t-Butylpheny1)5-(4''-biphenyly1) 
1,3,4,-oxadiazol
Ca Capillary
EC Enyzme Commission
g glycogen
h 11 contraction band
In Interstitial space
L Lipid
M Mitochondria
Mf Myofiber
mg % weight in milligrams per 100 milliliters
Q°2 Maximum rate of oxygen consumption in the presence of ADP
rbc Red blood cell
RCR Respiratory Control Ratio
Sa Sarcoplasm
SDS Sodium dodecyl sulfate
SEM Standard error of the mean
SR Sarcoplasmic reticulum
TCA Trichloroacetic acid
z Z contraction band
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CHAPTER 1
INTRODUCTION
1.1 History
Throughout the years, alcohol has been appreciated, 
craved, respected, abhorred, and feared; but it has never 
been thoroughly understood. Excessive consumption of 
alcohol was known to be related to liver disease before 
the time of Hippocrates (Rubin, 1979). In the past cen­
tury, especially the past two decades, alcohol-related 
diseases have become widely recognized in every system of 
the body, especially the digestive, nervous, muscular, cir­
culatory, and endocrine systems, producing damage in most 
organs of these systems. Of particular interest in this 
investigation is the effect of excessive chronic alcohol 
consumption on the heart muscle.
A causal association between alcoholism and heart 
disease was first described in 1873 by Walshe as "a local­
ized form of cirrhosis occurring in the myocardial wall and 
trabeculae carneae in the absence of impaired coronary cir­
culation” ( Walshe , 1873). In 1884, Bollinger introduced 
"München Bierherz" in describing cardiac hypertrophy in 
chronic beer drinkers and warned that with excessive 
habitual use of beer one has to take into account the 
direct toxic effect of alcohol on the heart (Bollinger, 
1884). Steell (1893) commented on the causal effect of 
alcohol on muscle failure of the heart as a comparatively 
common one, and 1902, Mackenzie coined "alcoholic heart 
disease" in his monograph Study of the Pulse (Mackenzie,
1902).
Widespread interest in alcohol consumption and heart 
disease was not stimulated until Aaalsmer and Wenckebach 
(1929), Keefer (1930) and Weiss and Wilkins (1937) describ­
ed a condition associated with excessive alcohol consump­
tion known as beriberi heart disease. Beriberi is a 
nutritional disorder which shows a dramatic positive res­
ponse to thiamine (vitamin B^) administration. There have 
also been reports of alcoholic cardiomyopathic epidemics 
among drinkers of large quantities of beer in Quebec in 
1965 (Morin, 1969) and in Omaha, Nebraska in 1966 
(McDermott, 1966). The causative factor was determined to 
be a cobalt metal additive in the beer. Upon removal of 
cobalt, the epidemic vanished. Cobalt has been described 
as an intensification factor in alcohol toxicity.
Due to the rarity of beriberi heart disease and the 
relative frequency of heart disease in alcoholic patients a 
direct causal relationship was maintained by several astute 
clinicians (Brigden, 1957; Evans, 1959; Hickie and Hall, 
1960; Wendt et al., 1962; Burch and Walsh, 1960). In 
1957 Brigden introduced the term "cardiomyopathy" to indi­
cate "isolated non-coronary myocardial disease". It was 
soon shown that many patients with a history of heavy al­
cohol consumption and congestive heart failure did not res­
pond to thiamine, displayed a different prognosis than the 
beriberi syndrome, and showed no clinical evidence of mal­
nutrition or vitamin deficiency. (Burch and Walsh, 1960; 
Evans, 1961; Brigden and liobinson, 1964).
There is now much evidence that alcohol exerts a 
direct toxic effect on the myocardium, although the idea
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has been slow to gain acceptance, partly because ol 
confusion with thiamine deficiency, the cobalt toxicity 
epidemic and certainly because of difficulty in documenting 
people's drinking history.
1.2 Prevalence
Alcoholic cardiomyopathy is not a disease of 'skid- 
row' individuals, in fact, not more than 5% of alcoholics 
are such types. Alcoholic heart disease prevails either in 
isolation or more rarely in association with liver cirrhosis 
or neuropathy. It occurs in persons of every social class 
and in any country (Burch and De Pasquale, 1969). In 1974, 
Australians consumed more than 10 liters of absolute alco­
hol per person to lead the English speaking world in con­
sumption. This amount has been increasing since that 
time (Lehare, 1979). In the Western world alcohol abuse 
may be the major cause of cardiomyopathy. Although not 
every chronic alcoholic may actually develop cardiomyopathy, 
cardiac malfunction can be found to varying degrees upon 
continual, heavy consumption (Rubin, 1979).
Any doubts as to the direct effects of alcohol on 
the heart, as well as the rest of the body, should be dis­
pelled within the next few decades as drinking becomes ever 
increasingly an intrinsic aspect of -our way of life.
1.3 Clinical Signs
A recent comparative study of patients with alcohol­
ic cardiomyopathy and those in whom the myocardial disease 
could not be linked to alcohol, suggested that the alcohol­
ic variety is particularly dangerous. There is nothing
specific about the onset which may be insidious, showing 
vague clinical signs or sudden death from congestive heart 
failure.
The clinical symptoms include dyspnea (shortness of 
breath), palpitations, chest pain, fatigue, and are further 
signalled by tachycardia, arhythmias mainly as atrial 
fibrillation, low output, and a pulse of small volume. In 
later stages, cardiac enlargement, decreased left ventric­
ular function and cold blue limbs are evident. These find­
ings are in direct contrast with beriberi, characterized by 
hyperdynamic circulation, increased cardiac output, warm 
skin and bounding pulse. ( Demakis et al. , 1974; Gunner 
et al. , 1975; Burch and De Pasquale, 1969; Brigden, 1964; 
Evans , 1961) .
Additional criteria for diagnosis used by clinicians 
and assumed throughout this discussion include congestive 
heart failure in the absence of hypertension, coronary, 
valvular, congenital or nutritional diseases in the pres­
ence of alcoholism. (Demakis et al. , 1974).
1.4 Hemodynamic Studies
Approaches to determining the effect of ethanol on 
cardiac performance and coronary blood flow in experimental 
animals are varied. Regardless of method, the primary 
effect of alcohol ingestion on cardiac performance is loss 
of cardiac contractility.
Infusion experiments using dogs with moderate 
( 75-200 mg %) blood ethanol levels show a decrease in myo­
cardial contractile force eventuated by diminished left 
ventricular function and decreased coronary blood flow.
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(Degerli and Webb, 1964; Regan et al. , 1966). Mierzwiak 
et al. (1967) showed a dose-dependent relationship for left
ventricular functional changes and depression could only be 
observed at high blood ethanol levels (300 mg %).
In chronic experiments, response may be time-depend­
ent as well as dose-dependent. Segal et al. (1975) demon­
strated definite mechanical impairment in isolated rat 
papillary muscle after administration of a 25% aqueous 
ethanol solution for 5 months, but saw no effect in those 
animals receiving a 5% aqueous solution over the same per­
iod. Gimeno et al. (1962) showed that at moderate levels,
an almost linear relation existed between concentration of 
ethanol and myocardial contractility in isolated rat atria. 
Furthermore, Pachinger et al. (1973) demonstrated no
hemodynamic abnormalities in dogs receiving 36% of their 
daily calories as ethanol for 14 weeks, but Regan et al. 
(1974) increased the duration of study in the same experi­
mental group to 22 months and showed increased diastolic 
stiffness of left ventricular muscle.
"Alcohol adaptation" in cardiac performance by 
chronic ethanol treated rats was shown when studied in con­
junction with the effects of an acute administration of 
ethanol to otherwise normal rats (Lochner et al., 1969). 
Adaptation is also well documented for human alcoholic sub­
jects as shown by a dose response relation not evident in 
non-drinkers (Regan et al., 1969).
1.5 Pathology
Gross examination of the heart in patients with al­
coholic cardiomyopathy reveals dilation of all cardiac
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chambers with significant dilation of the left ventricle 
(Brigden, 1964; Burch and De Pasquale, 1969). As a result, 
the heart has assumed a "boot-shaped" appearance.
The myocardium appears pale and flabby. Diffuse 
areas of macroscopic fibrosis, especially in the left ven­
tricle, as well as endocardial lesions consisting of patchy 
areas of fibroelastic thickening are apparent. Coronary 
vessels are patent and valves are normal (Brigden, 1964;
Burch and De Pasquale, 1969).
Light microscope studies show small scattered areas 
of muscle degeneration, patchy fibrosis, loss of cross 
striation, and focal necrosis. Interstitial edema was 
common, especially in affected areas (Hibbs et al., 1965: 
Burch and De Pasquale, 1969).
By electron microscopy, widespread changes have 
been identified in human myocardium obtained upon biopsy or 
at autopsy. The most striking changes were seen in the 
ultrastructure of the mitochondria. There were increased 
numbers of mitochondria, at times appearing in solid sheets 
to the exclusion of other cellular constituents. Many were 
swollen 2-3x their normal size, showing tremendous varia­
tion in shape. The cristae were degenerate giving a "moth 
eaten" appearance. Intramitochondrial inclusions were seen 
as further evidence of total mitochondrial degeneration 
(Hibbs et at., 1965; Alexander, 1966).
Also prominent in these studies was the loss or 
degeneration of contractile elements. The myofibrils were 
fragmented or completely absent, replaced by edema fluid or 
sarcoplasmic reticulum vessicles. In areas of greatest 
damage, the sarcoplasmic reticulum was completely
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disorganized and only dilated spherical vessels remained.
Hibbs et al. (1965) emphasized that the extent of 
these changes varied greatly and were not localized. The most 
consistent finding of his post-mortem study was the presence 
of numerous lipid droplets throughout the myocardium, even 
in areas in which no other ultrastructural alteration was 
demonstrated. The deposition of large amounts of glycogen 
was also apparent.
Histochemical studies by Ferrans et al., (1965) 
support the finding that lipid deposition is increased in 
necrotic cardiac tissue, and is found mainly as triglycer­
ides. Fluorescence studies show a change in distribution 
of this neutral lipid from the interfibri1lary spaces to 
the cytoplasm of the myocardial fibers, indicating diffuse 
cellular damage.
Mitochondrial damage was further demonstrated his- 
tochemically by a pronounced loss of staining reactions for 
several oxidative enzymes, especially succinic dehydrogen­
ase, lactate dehydrogenase, malate dehydrogenase, cyto­
chrome oxidase and DPN-diaphorase (Ferrans et al. , 1965).
These findings in studies with post-mortem and 
biopsy specimens from patients with alcoholic cardiomyo­
pathy correlate well with experimental models defined by 
strict dietary regimens.
In experiments with rhesus monkeys, Vasdev et al. 
(1975) noted the gross appearance of the heart to be flabby 
and epicardial fat was increased in animals fed ethanol for 
3 months. Enlarged, globular shaped hearts due to dilation 
of both atrial and ventricular chambers were found in 
hearts from ethanol fed rats (Rossi, 1980).
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Light microscopic examinations showed evidence of 
fatty infiltration in muscle fibers of monkey and mice 
hearts (Vasdev et al. , 1975; Alexander et al. , 1977b) as 
well as minor hydropic degeneration of myofibrils, includ­
ing loss of striations in mice (Alexander et al., 1977b; 
Burch et al., 1971). In addition, vacuolization, hyaliniz- 
ation, foci of cellular exudation and muscle fiber swelling 
has been demonstrated in ethanol fed rats at low magnific­
ations (Rossi, 1980).
Many additional features, especially those changes 
involving the mitochondria and contractile elements were 
observed under electron microscopic examinations. Mito­
chondria appeared enlarged and vacuolated due to the 
cristae which were swollen or had ruptured and completely 
disappeared (Alexander et al., 1977b; Rossi, 1980; Burch 
et al., 1971; Segal et al., 1975). In some cases mito­
chondria were more numerous and had clumped into aggregates 
pushing aside the myofibrils (Alexander et al., 1977b;
Segal et al., 1975). The myofibrils were disoriented and 
disorganized, showing fragmentation and separation by edema 
fluid (Alexander et al., 1977b; Rossi, 1980), indicative 
of a disturbance in the structural integrity of the 
sarcomeres.
Swollen sarcoplasmic reticulum and transverse tub­
ules appeared as dilated round profiles, often described as 
vesicles. Dehiscence of the fascia adherens portion of 
the intercalated disc was common (Burch et al., 1971; 
Alexander et al., 1977b; Segal et al., 1975; Rossi, 1980).
Neutral lipid in the form of triglycerides was 
found to accumulate in the heart muscle cells causing
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distortion oi structure (Vasdev et al., 1975; Alexander 
et al. , 1977b) and between the mitochondria which appeared 
to surround and engulf the droplets (Burch et al. , 1971). 
Although these findings of lipid accumulation are reminis­
cent of the human studies, it is important to note that 
several investigators failed to report any significant in­
crease in lipid deposits (Segal et al., 1975; Rossi, 1980; 
Hall and Rowland, 1970).
Glycogen granules were present (Hall and Rowland, 
1970; Alexander et al., 1977b), although it is not clear 
whether amounts were increased (Burch et al., 1971).
Deposits of an amorphous electron dense granular material 
were seen in the mitochondria (Alexander et al., 1977b) and 
the T-system (Burch et al., 1971). It has been suggested 
that at least in the mitochondria this material may be 
calcium deposits.
Histochemical staining methods (Vasdev et al., 1975) 
complimented these ultrastructural observations especially 
in differentiating degenerative muscle fibers from normal 
ones. Patches in the myocardium of ethanol fed monkeys 
showed gross variations in size of muscle fibers, fragmen­
tation, and loss of striation. In addition, sites of mus­
cle atrophy and nuclear atypism were apparent in some areas.
Occasional alterations in the staining reactions 
for 3-hydroxybutyric dehydrogenase and succinic dehydrogen­
ase were found in alcohol fed mice when compared with 
normal controls, while lactate dehydrogenase appeared hom­
ogeneous in both (Alexander et al., 1977a).
It is important to note that the widespread pathol­
ogic changes of the myocardium related to the consumption
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of alcohol are non-specific. Similar changes are seen in 
experimental myocardial ischemia and anoxia (Jennings et 
al. , 1965; Hibbs et al. , 1965), potassium deficiency 
( Burch et al. , 1971; Molnar et al., 1962) and magnesium
deficiency (Mishra, 1960). Biochemical studies more refin­
ed than histopathological techniques are necessary to 
investigate further the relationship of ethanol consumption 
to heart disease as it affects complex metabolic processes.
1.6 Mitochondria
The molecular and cellular events characteristic of 
congestive heart failure associated with excessive and pro­
longed consumption of alcohol are largely unknown. In the 
light of widespread and extensive mitochondrial degenerat­
ion as shown by ultrastructural and histochemical techni­
ques, biochemical investigations into mitochondrial function 
and integrity were necessary.
The criteria for mitochondrial integrity as defined 
by Chance and Williams (1956) are based on tight coupling 
of oxidation and phosphorylation in mitochondria. The 
parameters of oxidative phosphorylation which can be measur­
ed polarigraphically include, a) the phosphorylation 
efficiency expressed as ADP/0, b) respiratory control 
ratio (RCR) which is expressed as the ratio of oxygen consumed in 
the presence of ADP (State 3) to that after the ADP has 
been phosphory1ated (State 4), and c) the rate of rapid 0^ 
consumption during phosphorylation expressed as QOg•
Even in the early pathogenesis of alcoholic cardio­
myopathy, a fall in the rate of 0  ^ consumption and RCR 
values is evident. Experiments with dogs and rats using
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various respiratory Site I substrates such as glutamate- 
oxalacetate, a-ketoglutarate, pyruvate-malate, and the Site 
II substrate succinate indicate a non-specific overall loss 
of mitochondrial functional integrity (Sarma et al. , 1976; 
Pachinger et al. , 1973; Segal et al. , 1975; Bing, 1978; 
Williams and Ting-Kai, 1977; Shishov et al. , 1977). No 
significant changes in ADP/O ratio were observed with 
chronic ethanol treatment.
Dysfunction of mitochondria resulting from loss of 
structural integrity, i.e. alterations in membrane permea­
bility has been proposed (Wendt et al., 1965; Pachinger et 
al., 1973; Williams and Ting-Kai, 1977). Loss of activity 
in several intramitochondrial enzymes, and evidence of 
enzyme leakage into the coronary sinus certainly support 
this hypothesis.
1.7 Mechanisms of Contraction
As with mitochondria, the degeneration of contrac­
tile elements of the myocardium was an outstanding lesion 
in pathological studies of alcoholic cardiomyopathy. It is 
apparent clinically as loss of myocardial contractility and 
efficiency (Regan et al., 1966; Abel, 1980). Diminished 
contractility, the hallmark of myocardial failure may 
result from a variety of molecular disturbances.
Contraction of muscle requires a proper ionic milieu, 
maintained by the sarcolemma (plasma membrane). An ab­
normal distribution of electrolytes reflected by a reduc­
tion of cellular potassium and phosphate ions and increased 
sodium ion concentrations in chronic ethanol-treated dogs 
(Regan et al., 1966; Ettinger et al., 1971; Israel, 1970)
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and rats (Lochner et al., 1969), indicates cell damage of 
the sarcolemma. Leakage of electrolytes and myocardial 
enzymes is further evidence for extensive tissue damage in 
human subjects (Wendt et al., 1965).
Excitation-contraction coupling may be disturbed by 
impaired mitochondrial respiration as well as interference 
with activities of the sarcoplasmic reticulum. These 
deficiencies are exemplified by deficiencies in the calcium 
delivery system. Bing et al., (1974), have shown that 
ethanol inhibits both calcium binding and uptake in the 
mitochondria and sarcoplasmic reticulum. Endogenous calcium 
content is also diminished in the myocardium of chronic 
ethanol-treated dogs (Sarma et al. , 1976).
Furthermore, proper functioning of contractile and 
regulatory proteins and myofibrillar ATPase activity cannot 
be overlooked in this complex process. Although ethanol 
itself has not been identified, the intermediary metabolite 
acetaldehyde profoundly effects ATPase activity and there­
fore proper functioning of the actomyosin-troponin complex 
(Bing, 1978).
1.8 General Metabolic Outlook
Before discussing the metabolic effects of chronic 
alcohol consumption on the heart, a brief review of the 
metabolism of alcohol in general is indicated. Ethanol, 
the active metabolite of alcoholic beverages, is rapidly 
absorbed in the gastrointestinal tract and distributed 
throughout the body. Only 2-10% of the ethanol absorbed 
can be eliminated as such via the kidneys and lungs (Chafetz, 
1979; Lieber, 1975). The toxic effects of alcohol on the
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liver may be connected with the action of alcohol dehydrog­
enase (EC 1.1.1.1), the principle enzyme in ethanol metab­
olism. This concept rests on the fact that alcohol affects 
the liver more than any other tissue (apart from the cent­
ral nervous system) and that this selective action is 
paralleled by the distribution of alcohol dehydrogenase 
(Krebs, 1968). In human liver the activity ot this enzyme 
is more than 30 times greater than that of the next most 
active tissue, the gastric mucosa.
In the initial step of breakdown, (Fig. 1.1) ethanol is 
oxidized in the cytoplasm to acetaldehyde by alcohol dehy­
drogenase, simultaneously reducing its pyridine nucleotide 
cofactor NAD+ to NADH. Acetaldehyde is subsequently 
oxidized to acetic acid by acetaldehyde dehydrogenase 
(EC 1.2.1.3) primarily in the mitochondria also forming NADH
(Lundquist, 1975; Tottmar et at., 1973). In the normal 
NAD+liver, the ratios of the cytoplasm and mitochondria
are regulated and maintained within narrow limits (Krebs,
1968). The pyridine nucleotide ratios are of importance to 
the control of several metabolic processes as described 
below.
In the cytoplasm, a fall of the NAD ratio inNADH
favor of reduction is accompanied by an increase in the
lactate ratfo. The shift towards reduction affects the pyruvate
lactate dehydrogenase (EC 1.1.1.27) system, resulting in a 
substantial decrease in the,steady state concentration of 
pyruvate. This decrease acts to reduce the expression of 
rate limiting pyruvate carboxylase (EC 6.4.1.1), the first 
step in the pathway to gluconeogenesis. Gluconeogenesis 
from the precursors glycerol, dihydroxyacetone phosphate,
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proline, serine, alanine, fructose and galactose is also 
inhibited by the effect of ethanol of the redox state of 
the NAU+ system (Krebs, 1968).
Another consequence of the shift to reduction in the 
lactate dehydrogenase system is the increased concentrations 
of lactate. This is apparent since blood lactate concen­
trations are elevated in chronic alcoholics causing acido­
sis or hyperlactacidemia (Krebs, 1968; Lieber, 1975).
Acidosis in turn reduces the excretion of uric acid from 
the kidneys causing hyperuricemia (Lieber, 1975; Handler, 
1960).
Ethanol metabolism affects other dehydrogenase 
systems. Of critical metabolic importance is the 
a-glycerophosphate dehydrogenase (EC 1.1.1.8) reaction 
which is pushed in favor of the formation of the reduced 
substrate a-glycerophosphate (Krebs, 1968; Nikkilä and Ojala, 
1963). The accumulation of a-glycerophosphate is small due 
to feedback inhibition but disturbance of its metabolism 
still has major physiological consequences (Blancher, 1965). 
a-Glycerophosphate is the primary substrate for and controls 
the rate of triglyceride synthesis according to the follow­
ing equation:
a-glycerophosphate + 3acyl-CoA----->triglyceride + 3CoA + phosphate
Since fatty acyl-CoAs are esterified in response to increas­
ing levels of a-glycerophosphate, the regulatory inhibition 
of the synthesis of acyl-CoA is released (Krebs, 1968;
Lieber, 1975). The relevant point here is that one of the 
earliest features of alcoholic liver disease is the
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deposition of fat (Kramer et al. , 1968; Lieber et al. ,
1963; Lieber et al., 1965). Increased concentrations of 
a-glycerophosphate may also serve to inhibit glycogenolysis 
in the fasted animal or undernourished individual (Krebs,
1968) .
NAD+In the mitochondria, a fall in the <7.yuf ratio in’ NADH
response to liver metabolism of ethanol, is reflected in
,, , , , . hydroxybutyrate , , , ,the increase m  the redox pair — —    — -— £----  and probably ^ acetoacetate
results from acetaldehyde oxidation as well as from 
"shuttling" of H+ from the cytoplasm via malate or 
a-glycerophosphate (Lundquist, 1975; Lieber, 1975). The 
effect of an increased reduction of NAD+ in the mitochond­
ria is the depression in the activity of the tricarboxylic 
acid cycle and a decrease in fatty acid oxidation. The 
depression of the tricarboxylic acid cycle is probably due 
to the slowing of reactions that require NAD+ (Lundquist,
1975), and shunting of citrate out of the mitochondria 
(Forsander et al., 1965). Fatty acids therefore are sup­
planted by ethanol for 11+ equivalents resulting in 
decreased oxidation of fatty acids and triglyceride 
accumulation (Lieber, 1975).
In addition to the oxidation of ethanol by alcohol 
dehydrogenase, liver cells have an auxiliary system for 
ethanol metabolism known as the microsomal ethanol oxidiz­
ing system (MEOS) (Lieber, 1975; Lundquist, 1975). Micro­
somal oxidations may involve peroxidation by catalase or a 
hydroxylation system involving NADPH oxidases (Fig. 1.1). The most 
significant aspect of microsomal oxidations is the energy 
cost. Microsomal oxidations are not coupled to phosphory­
lation, thereby producing heat that is not converted to
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Chemical energy. The result is that ethanol calories don't 
"count" in this system and may result in lesser growth due 
to energy wastage (Lieber, 1975; Lundquist, 1975).
As mentioned above, the outstanding feature in the 
pathogenesis of alcoholic liver disease is the deposition 
of fat as neutral triglycerides. In addition to the roles 
of a-glycerophosphate and decreased fatty acid oxidation in 
the increased production of triglycerides, it is possible 
that fatty acid synthesis is stimulated by the increased 
production of acetyl-CoA from acetaldehyde oxidation and 
increased formation of NADPH by the transhydrogenase reac­
tion with NADU (Lieber, 1975; Lundquist, 1975). An 
increase in fatty acid synthesis and esterification to 
triglycerides would contribute to triglyceride accumulation. 
Furthermore, it has been reported that in alcoholic keto­
acidosis the adipose tissue exhibits an exaggerated 
lipolytic response to ethanol ingestion resulting in in­
creased mobilization of free fatty acids and ketone bodies 
which are transported to the liver, further increasing the 
lipid pool (Levy et al., 1973).
As fatty acids accumulate and triglyceride formation 
is favored, fatty liver results, followed by an adaptive 
capacity of the liver to rid itself of triglycerides by 
increased lipoprotein secretions (Baraona et al., 1973; 
Hernell and Johnson, 1973; Lieber, 1975).
In contrast to the liver, the heart contains no 
appreciable alcohol dehydrogenase activity and is not sig­
nificantly involved in the metabolism of ethanol (Lochner 
et al., 1969; Bing, 1978; Opie, 1969). Despite the oxi­
dative inertness of the heart to ethanol, alcoholic
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cardiomyopathies are a definite clinical entity. Pathogen­
esis of this disease must be due to the direct toxic effects 
of alcohol on cardiac metabolism and the heart's conduction 
system, or stem from secondary effects of ethanol metabolism 
in the liver.
1.8.1 Cardiac Lipid Metabolism
Nutrient uptake studies of the heart in vivo have 
shown that glucose,pyruvate, lactate, amino acids, ketone 
bodies and free fatty acids are readily absorbed from the 
blood and utilized by the heart. In normal plasma, however, 
amino acids and ketone bodies are present in small amounts 
and don't contribute significantly to the energy demands of 
the heart. Plasma glucose and free fatty acid levels are 
adequate as energy sources, but while glucose may decrease 
the oxidation of fatty acids the metabolism of fatty acids 
is not abolished in the presence of high glucose concentra­
tions (Gilbertson, 1977). Further experiments with isolated 
hearts show that cardiac glycogen reserves are excluded as 
important energy sources (Gartner and Vahouny, 1973).
Plasma free fatty acids are therefore considered to be the 
nutrient of major physiological importance in cardiac 
muscle metabolism (Gilbertson, 1977; Fritz, 1961;
Greville and Tubbs, 1968). Bearing this in mind it is sig­
nificant to the elucidation of the role of metabolism in 
the pathogenesis of alcoholic cardiomyopathy that lipid 
dissimilation is profoundly affected by acute and chronic 
ethanol treatment.
In the presence of moderate levels (75-200 mg %) of 
ethanol (Regan et at. , 1975) the hearts of normal and chronic
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ethanol-treated animals show a signii'icant alteration in 
fatty acid metabolism. Although myocardial fatty acid up­
take was unchanged (Regan et al., 1975), incorporation of 
fatty acids into tissue triglycerides was significantly 
increased. Chemical analysis showed a 2-3 fold increase in 
myocardial triglyceride content while COg production was 
decreased in the heart (Regan et al., 1966, 1969, 1971; 
Vasdev et al., 1975; Marciniak et al. , 1967; Alexander 
et al. , 1977a; Williams and Ting-Kai, 1977; Kikuchi and 
Kako, 1970; Lochner et al., 1969).
Excess myocardial triglyceride storage can result 
from (1) increased synthesis from the uptake of plasma 
free fatty acids, (2) increased fatty acid synthesis and 
esterification to triglycerides from non-lipid sources such 
as glucose and acetate, (3) increased uptake of plasma 
triglycerides, (4) alterations between lipid classes, and 
(5) reduced utilization of fatty acids and storage as tri­
glycerides due to impaired oxidative machinery or myocardial 
usage of an alternative substrate.
Free fatty acids are transported to the heart non- 
covalently bound to plasma albumin. Albumin-bound free 
fatty acids are transferred from the plasma albumin to the 
capillary membrane where the fatty acids are transferred to 
albumin in the interstitial space. The plasma membrane con­
tains certain binding sites specific for the uptake of 
fatty acids by the heart cell (Gilbertson, 1977).
Net uptake is reflected by the plasma concentrations 
of free fatly acids (where the possibility of exchange with 
endogenous fatty acids has been ruled out) and the availa­
bility of competing substrates, especially pyruvate and
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acetoacetate (Gold and Spitzer, 1964; Evans et al. , 1963; 
Olson, 1962). At times when the heart demands more energy 
as during an increased work load, an increase in the turn­
over rate of the plasma membrane binding sites, independent 
of free fatty acid levels may serve to increase fatty acid 
uptake (Oram et al. , 1975) . Uptake of plasma free fatty acids is 
hormone insensitive (Greville and Tubbs, 1968; Fritz, 1961).
It is doubtful if myocardial triglyceride accumu­
lation occurs by an increase in fatty acid uptake (1) for 
despite a transient increase in plasma free fatty acid 
levels due to an ethanol dose, plasma levels are unchanged 
after prolonged ethanol consumption (Regan et al. , 1974; 
Kikuchi and Kako, 1970). Fatty acid extraction by the 
heart may in fact be diminished as a consequence of ethanol 
administration (Regan et al., 1966, 1974; Ferrans et al., 
1965). Furthermore, the availability of competing sub­
strates would only serve to decrease fatty acid uptake and 
there is no evidence that ethanol treatment imposes an 
increased energy requirement on the heart.
Lipogenesis (2) is an unlikely explanation for tri­
glyceride accumulation since de novo synthesis of fatty 
acids is not a notable function of the heart and occurs 
mainly in adipose tissue where lipids are stored (Greville 
and Tubbs, 1968; Fritz, 1961). Cardiac tissue does not 
contain a significantly active classical biosynthetic path­
way for fatty acid synthesis although the mechanism may be 
different than other tissues (Opie et al.} 1963). Evidence 
supporting an alternative synthetic mechanism and function 
stems from the facts that the anabolic activity is found to 
be associated with the mitochondrial fraction rather than
2 0 .
the cytosol (Wit-Peeters e t a £ . , 1970; Whereat etal.} 1969) and 
the regulatory enzyme is propiony1-CoA caroboxylase (EC 
6.4.1.3) rather than acetyl-CoA carboxylase (EC 6.4.1.2) as 
in other tissues. The pathway of fatty acid synthesis in 
cardiac tissue seems to act more like a reversal of the 
3-oxidation mechanism. As in the classical synthetic pathway, 
however, increased ratios in the myocardial cell
favoring reduction are necessary for synthesis to occur 
(Gilbertson, 1977; Whereat ct at., 1969).
Because of the limited role of fatty acid synthesis 
de novo in cardiac tissue it is unlikely that significant 
triglyceride deposition would result from this process. 
Furthermore, measurement of the cytoplasmic and mitochon­
drial redox pairs indicate that the redox state of the 
heart is more oxidized (Kikuchi and Kako, 1970) or unchang­
ed (Regan et al., 1966).
In addition to the utilization of circulating free 
fatty acids, the heart utilizes the fatty acids of circulat­
ing triglycerides. Triglycerides are transported in the 
plasma as lipoprotein complexes - chylomicrons (secreted 
from the gut after a fatty meal) and very low density lipo­
proteins, VLDL (secreted by the liver)(Greville and Tubbs, 
1968). The triglyceride portion of these lipoproteins 
cannot be transported directly into the heart cell for oxi­
dation but must be hydrolyzed to fatty acids which then may 
enter the cell. The enzyme lipoprotein lipase (EC 3.1.1.3) 
catalyzes the hydrolysis of the triglycerides of plasma 
chylomicrons and VLDL to glycerol and free fatty acids.
The lipoprotein lipase enzyme appears to reside at the level 
of the capillary endothelium and is important in the
physiological adaptation of the heart to various nutrition­
al states (Gilbertson, 1977). In situations where the 
heart catabolizes an increased quantity of fatty acids, for 
example during fasting or when there is an increased work 
load, the activity of lipoprotein lipase shows a substant­
ial (4-8 fold) increase. Feeding of glucose, but not an 
isocaloric amount of olive oil to the fasted animal return­
ed the enzyme level to normal (Gilbertson, 1977).
Increased uptake of triglycerides by the heart (3) 
from VLDL which originated from the liver in response to 
acute ethanol treatment has been suggested (Regan et al. , 
1974). However, the transient increase in cardiac lipo­
protein lipase activity in response to an ethanol dose was 
not observed (Kikuchi and Kako, 1970). Nor were plasma 
triglyceride levels found to be particularly elevated in 
the chronic ethanol-treated animal. Finally, experiments 
using heart tissue homogenate metabolizing palmitate in the 
presence of ethanol showed increased esterification of 
fatty acids in the absence of exogenous triglyceride 
(Kikuchi and Kako, 1970).
Myocardial triglyceride accumulation could result 
from (4) a shift in the normal lipid composition of the 
heart in response to ethanol treatment. Animal tissue- 
lipids can be divided into two categories; 1) that portion 
of tissue lipid which is essential in cell structure, aptly 
termed the essent ial lipids, and 2) those lipids which 
function as storage depots either for metabolic fuel or as 
pro tec tive components of cell wa1 Is (Willi ums cL al. , 1945; 
Christie, 1973). The essential lipids of animal tissues 
can be divided into three groups, a) the cholesterol esters
and free cholesterol, b) the phospholipids and c) the 
sphingolipids. Each of these groups can be further divided 
into several classes. A good review of all lipid classes 
can be found in an account by Christie (1973). As a general 
rule the essential lipids function as important components 
of the cell membrane. The lipids of the storage depots 
comprise the major portion of lipid in the body and consist 
almost entirely of the triglycerides of 'neutral fat'.
The concentration and distribution pattern of 
various lipid classes varies among different tissues to the 
extent and variety of their physiological function.
Studies on the lipid composition of various rat tissues 
show that the heart, which functions primarily as an oxi­
dative center, contains a very small amount of neutral 
storage fat, the major lipid component being the phospho­
lipids of the cellular membranes (Williams et at., 1945).
The importance of phospholipids to the structure and inte­
grity of cellular membranes suggests that ethanol induced 
alterations in the ultrastructure of the heart (Ferrans et 
al., 1965; Alexander, 1966) may be related to changes in 
the composition or distribution of phospholipids. It is 
interesting to consider that a decrease in membrane phos­
pholipids by periods of rapid hydrolysis and liberation of 
free fatty acids could account for an increase in triglyc­
erides. It has been shown however, that chronic ethanol 
ingestion produced only minor changes in phospholipid 
composition (Reitz, 1980). These changes were due to an 
alteration in fatty acid composition, and may account for 
the decreased incorporation of specific fatty acids to 
phospholipids as a result of ethanol treatment (Regan et al.}
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1975). Changes in total phospholipid concentration, how­
ever, were not observed. It is not likely in view of the 
lipid composition of cardiac tissue that alterations in 
lipid classes (4) could account for the dramatic increases 
in triglyceride observed.
It is generally believed that myocardial triglycer­
ide accumulation resulting from ethanol treatment is a con­
sequence of reduced utilization of fatty acids (5) (Vasdev et 
al., 1975; Williams and Ting-Kai, 1977; Rubin, 1979).
Fatty acids within the cell are obtained from 3 pools: 
a) hydrolysis of endogenous triglycerides, b) uptake of 
albumin bound fatty acids and c) lipolysis of lipoprotein 
triglycerides. These fatty acids may be bound to intra­
cellular proteins or a unique low molecular weight cyto­
plasmic protein specific for long chain fatty acids (Mish­
kin and Turcotte, 1974; Van Golde and Van den Bergh, 1977). 
The major fate of these fatty acids is oxidation to CC^, only 
a small portion are converted to complex lipids.
A redirection of the metabolic fate of fatty acids 
in the heart from oxidation to COg towards esterification 
to complex lipids occurs if other oxidizable substrates are 
simultaneously available, especially pyruvate and ketone 
bodies. It has been shown that in the presence of high 
concentrations of acetoacetate in the blood, both glucose 
and fatty acid metabolism are inhibited in the heart and 
total oxygen consumption is attributed to acetoacetate 
metabolism (Bassenge et al. 3 1965).
In the liver the metabolism of ethanol results in an 
increased production of acetate (which may be converted to 
acetyl-CoA), lactate, and ketone bodies which are
transported in the plasma i’or utilization by peripheral 
tissues such as the heart. Whether plasma concentrations 
of these substrates ever reach inhibitory levels or 
whether all of these substrates would inhibit fatty acid 
oxidation in the heart is not known.
Increased esterification of fatty acids to tri­
glycerides would also result from an impairment in the pro­
cess of fatty acid oxidation. A brief discussion of the 
complex process of fatty acid oxidation in the normal 
heart will be given here as it is believed that an ethanol- 
linked reduced utilization of fatty acids due to impaired 
oxidation is primarily responsible for the accumulation of 
triglycerides in alcoholic cardiomyopathy.
Oxidation of fatty acids in cardiac tissue involves 
the symbiotic action of 3 mitochondrial enzyme systems, 
a) the acyl-CoA synthetases (EC 6 .2.1.3), b) the carnitine 
acyl transferases (EC 2.3.1.7 and 2.3.1.21), and c) the 
enzymes of ß-oxidation (Gilbertson, 1977). For almost
all metabolic pathways in which fatty acids are involved, 
they must be activated with free CoA-SII to form the fatty 
acyl thiol esters at the expense of ATP. This 'activation' 
step involves a) acyl-CoA synthetase enzymes, which broadly 
speaking fall into 3 groups, each specific for either short 
(C2-C3 ), medium (C^-C^)» or long (C^2~C^g) c*ia:'-n fatty 
acids. Octanoate (Cg) is slightly different from all of 
the other fatty acids as it does not require an initial 
activation to be oxidized in the mitochondria.
ATP-1inked fatty acid activation follows the general reac­
tion: R-COOH + ATP + CoA-SH = = ±  R-CO-SCoA + AMP + PP^
Further details of the fatty acid activation are reviewed by
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Groot et at. (1976).
The second group of enzymes b) the carnitine acyl 
transferases function to catalyze the reversible transport 
of activated fatty acids across the otherwise impermeable 
inner mitochondrial membrane to the site of 3-oxidation. 
Transfer of activated fatty acid groups across the inner 
mitochondrial membrane is dependent on the carrier molecule 
L-carnitine (L-3-hydroxy-4-trimethyl-ammonium butyrate) 
shown by Fritz (1961). Recent work by Pande (1975) and
Ramsey and Tubbs (1975) have shown that in the carnitine 
mediated transfer the acyl group is transferred from its 
thioester linkage with CoA-SII to an ester linkage with the 
3-hydroxyl group of L-carnitine. The acyl group passes 
through the inner membrane mediated by a carnitine:acyl- 
carnitine exchange carrier located in the membrane, and is 
finally transferred to intramitochondrial CoA-SII. See Fig. 
1.2. Two enzymes catalyzing the reversible acyl-group 
transfer between CoA and carnitine are of particular import­
ance in cardiac lipid oxidation, each located on both sides 
of the inner membrane. These enzymes are carnitine acetyl 
transferase (Friedman and Fraenkel, 1955), and carnitine 
palmitoyl transferase (Norum, 1965) and once again are 
calssified according to their chain length specificity for 
short and long chain fatty acyl-CoAs respectively. Oxida­
tion of medium chain fatty acids will not be considered here 
and is discussed by Sol berg (197/1).
Following the transport of the activated fatty acyl 
groups through the inner mitochondrial membrane degradation 
of the carbon chain occurs by 3-oxidation. 3-oxidation is 
exclusively a mitochondrial process (Kennedy and Lehninger,
Fig. 1.2
Activation and Transfer of Hatty Acids
OUTER
MITOCHONDR
MEMBRANE
AL
CYTOPLASM
Carnitine <—
Fatty acyl-carnitine
Fatty acyl-CoA
CoA-SH
INNER
MilTOCHONDRIAL 
MEMBRANE
MATRIX
-Carnitine
->Fa11y acy l-carn i t ine
CoA-SH
Fatty acyl-CoA- -) J3-Oxidation
0  Fatty acyl-CoA Synthetase
© C a r n i t i n e  acy l- t ransferase
^C arn i t ine :  acyl-carnit ine 
v  exchange carrier
26 .
1949) and the enzymes involved are located on the matrix 
side of the inner mitochondrial membrane (Beattie, 1968).
The reactions by which saturated, straight chain fatty acyl- 
CoAs are broken down to acetyl-CoA units are shown in Fig. 
1.3 (Lynen and Ochoa, 1953). In the first step, acyl-CoA 
dehydrogenase (EC 1.3.99.3) catalyzes the dehydrogenation 
between carbons 2 and 3, forming a Irans double bond. Four 
distinct acyl-CoA dehydrogenase enzymes have been identi­
fied, each with different chain length specificity (Beinert, 
1963). These enzymes contain an FAD prosthetic group 
linked to the respiratory chain by a second flavoprotein, 
the electron transferring protein (ETF). The second reac­
tion is a hydration reaction catalyzed by enoyl-CoA hydra- 
tase (EC 4.2.1.17) forming 3-hydroxyacy1-CoA. There are no 
cofactors or metal ions required for the hydration and only 
one enzyme has been identified for all chain lengths (Hill 
and Teipel, 1971). A second dehydrogenation follows, form­
ing the product 3-keto-acy1-CoA. The reaction is catalyzed 
by the enzyme L-3-hydroxyacyl-CoA dehydrogenase (EC 
1.1.1.35) and shows a strict requirement for NAD and the L- 
isomer of the substrate. No chain length specificity has 
been observed for this enzyme (Wakil, 1963). In the final 
reaction of the spiral, the enzyme 3-ketoacy1-CoA thiolase 
(EC 2.3.1.9) catalyzes a thiolytic cleavage of the carbon 
chain between C-2 and C-3 by interaction with a molecule of 
free CoA-SIl. The products of thiolysis arc acetyl-CoA and 
an acyl-CoA shortened by 2 carbons. There are probably 2 
classes of the enzyme, one with wide chain length specific­
ity and the other which is highly specific for acetoacetyl- 
CoA (Staack et al., 1978). It is interesting to note that
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as degradation begins at the 3-carbon, fatty acid oxidation 
is aptly termed 3-oxidation, and because the same cycle of 
reactions is carried out with substrates that are shorter 
each turn, the breakdown of acyl-CoAs is referred to as the 
3-oxidation spiral.
Recent attempts to isolate the intermediates of 
3-oxidation have led to the suggestion that the fatty acid 
substrate is passed from enzyme to enzyme without being free 
in solution, at least during the operation of a full cycle 
of the spiral (Stanley and Tubbs, 1975).
In addition to the general route for saturated, 
straight chain fatty acid oxidation described above, oxi­
dation of odd-numbered carbon chains requires 3 additional 
enzymes, while oxidation of unsaturated fatty acids 
requires 2 additional enzymes (Van Golde & Van den Bergh, 1977). 
Neither of these routes nor the processes of a-oxidation 
(Stumpf, 1969) and m-oxidation (Anthony and Landau, 1968) 
of fatty acids will be discussed here.
It is evident from information reviewed that the 
overall rate of fatty acid oxidation in the heart is 
exceedingly variable depending on the plasma free fatty 
acid concentration which is in turn affected by the 
nutritional-hormonal status of the animal (Fritz, 1961). A 
second important variable which is potentially capable 
controlling the rate of oxidation is the partitioning of 
'activated' fatty acids between triacylglycerol synthesis 
and oxidation. These two pathways are quantitatively the 
most important in fatty acid metabolism. This would occur 
at the level of acylation of glycerol-P and carnitine. The 
key enzymes catalyzing the acylations are sn-glycerol-3-P
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acyl transferase (EC 2.3.1.15) and carnitine palmitoyl 
transferase, respectively. It has been shown repeatedly 
that the activity of these enzymes is also affected by 
changes in the nutritional and endocrine states of the 
animal (McGarry et al., 1973; Ontko, 1972; Van Tol, 1974).
The sequence of reactions leading to the degrada­
tion of activated fatty acids is well understood, but con­
flicting observations and suggestions exist regarding the 
rate-limiting step. Reactions thought to be rate-determining 
include those catalyzed by acyl-CoA synthetase (Bode and 
Klingenberg, 1964), carnitine-palmitoy1 transferase 
(Shepherd et al., 1966), and acyl-CoA dehydrogenase (Bunyan 
and Greenbaum, 1965). Recent evidence, however, suggests 
that the capacity for activation and transfer of fatty acid 
moeities greatly exceeds that for 3-oxidation (Bremer and 
Wojtczak, 1972; Cederbaum et al., 1975). There is recent 
evidence that acyl-CoA dehydrogenase is the rate-limiting 
step (Stanley and Tubbs, 1975) however, if the enzymes are 
organized in mitochondria in a multi-enzyme complex, it is 
possible that the inhibition of any of the component 
enzymes of the complex would result in inhibition of the 
complete pathway as shown by the selective inhibition of 
3-ketoacylthiolase (Fong and Schulz, 1978).
Since none of the enzymes of fatty acid oxidation 
are known to be regulated allosterically or by covalent 
modification, substrate availability or product inhibition 
are possible control mechanisms (Fong & Schulz, 1978). Thus, the 
activity of the thiolase enzymes may be regulated by the 
availability of free CoA-SH, regulation of 3-hydroxyacy1- 
CoA dehydrogenase by the mitochondrial ratio, (Bremer and
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Wojtczak, 1972), of carnitine palmitoyl transferase by the 
cytosolic carnitine concentration (McGarry et al. , 1973), 
and of palmitoy1-CoA synthetase by the cytosolic CoA-SH 
concentration (Oram et al., 1975).
An unequivocal identification of the rate-limiting 
step of fatty acid oxidation not only requires evaluation 
of all possible rate-limiting steps but also information 
regarding the intramitochondrial organization of the enzymes.
Very little information is available regarding the 
effects of ethanol on the enzymes which may be rate- 
limiting in the oxidation of lipids in cardiac mitochondria. 
There is evidence to indicate that the transport of fatty 
acyl groups into the mitochondria via the carnitine carrier 
and transferase enzyme was not affected by acute exposure 
to ethanol (Williams and Ting-Kai, 1977). Chronic ethanol 
treatment, however, was shown to depress the activity of 
the acetyl-CoA synthetase enzyme causing a reduction of 
acetate utilization in the heart. This suggests that the 
activation of substrates for oxidation in the mitochondria 
may be impaired by prolonged ethanol treatment (Alexander 
et al., 1977a).
1.8.2 Cardiac Carbohydrate Metabolism
While it is established that the amount of lipids 
catabolized by heart tissue may be a significant portion of 
total metabolism, the contribution of glucose and to a 
lesser extent, amino acid substrates to oxygen consumption 
is of considerable importance, especially under varying 
nutritional and hormonal conditions (Fritz, 1961).
Studies on several key myocardial enzymes in acute
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and chronic ethanol-treated animals show no deleterious 
effect of ethanol on carbohydrate metabolism. Of all the 
enzymes studied including oxidative enzymes of the tricar­
boxylic acid cycle - NAD- and NADP-isocitrate dehydrogenase 
(EC 1.1.1.41 and EC 1.1.1.42), and malate dehydrogenase 
(EC 1.1.1.37); glycolytoic enzymes - glyceraldehyde phos­
phate dehydrogenase (EC 1.2.1.12), phosphofructokinase 
(EC 2.7.1.11), pyruvate kinase (EC 2.7.1.40); and pentose 
phosphate pathway enzymes - glucose-6-phosphate dehydrogen­
ase (EC 1.1.1.49), aldolase (EC 4.1.2.13), and 6-phosphoglu- 
conate dehydrogenase (EC 1.1.1.44); only NAD-dependent 
isocitrate dehydrogenase showed any significant diminution 
in activity. This enzyme fulfills a key regulatory function 
in the tricarboxylic acid cycle but it is not clear whether 
the depression in activity is due to metabolic regulation 
or is a reflection of mitochondrial damage (Pachinger et 
al., 1973; Marciniak et al. , 1967; Alexander et al., 1977a; 
Williams and Ting-Kai, 1977; Sarma et al., 1976; Wendt 
et al. , 1965 ) .
14In perfusion experiments with C-labelled glucose,
14 14C-pyruvate, and C-acetate, Lochner et al. (1969) con­
cluded that moderate levels of ethanol had no toxic effect 
on glycolytic or tricarboxylic acid cycle enzymes in a 
normal or chronic ethanol-treated rat. Myocardial metabol­
ism of glucose was unchanged as glucose uptake, production 
of C09, lactate, and pyruvate as well as the incorporation 
of glucose into tissue glycogen were similar to control 
values. Uptake of pyruvate and acetate as well as CC^ pro­
duction from these substrates was unchanged by ethanol 
treatment, and although lactate production was depressed
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with acute ethanol treatment, chronic ethanol-treated rats 
showed normal lactate production from pyruvate.
1.8.3 Cardiac Protein Metabolism
The total regulation of cellular and metabolic 
activity includes not only the synthesis of enzymes and 
structural elements but also their subsequent removal when 
no longer required. This occurs either as a result of a 
change in physiological or nutritional status or as a part 
of a developmental change (Schimke et al. , 1968). Studies from a 
number of laboratories have indicated that protein turn­
over and its regulation can be important in determining the 
levels and response of specific proteins to hormonal 
(Berlin and Schimke, 1965), pharmacologic (Drysale and 
Munro, 1966), and nutritional variables (Schimke et al., 
1968). The pathogenesis of lipid accumulation, necrosis 
and fibrosis, as well as ultrastructural changes of mito­
chondria in alcohol-related diseases is still unknown.
From a theoretical point of view, changes in protein metab­
olism could be a common denominator of ethanol-provoked 
changes.
Recent investigations on hepatic protein metabolism 
have demonstrated that moderate levels of ethanol cause a 
decrease in liver protein synthesis (Jeejeebhoy et al.,
1972) as measured using isolated perfused livers (Rothschild 
et al., 1974; Kirsch et al., 1973), liver slices (Perin et 
al., 1974), hepatocyte suspensions (Morland and Bessesen, 
1977), and isolated liver ribosomes (Kuriyama et al., 1971; 
Murty et al., 1980). In the presence of physiological con­
centrations of ethanol and/or acetaldehyde, liver
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mitochondria from otherwise normal and also chronic ethanol- 
treated rats show a pronounced decrease in protein synthes­
is, in vitro and in vivo (Burke and Rubin, 1979; Rubin, 
1979). Relatively low concentrations of ethanol or acetal­
dehyde inhibit protein synthesis by isolated skeletal 
muscle, and skeletal muscle mitochondria also show depressed 
protein synthesis after prolonged ethanol ingestion (Rubin 
et a l. , 1970b).
There is insufficient information regarding the 
effects of ethanol on cardiac protein turnover. Perfusion 
studies with acetaldehyde, however, showed a decrease in 
total and microsomal protein synthesis in rat heart 
(Schreiber et al., 1972, 1974). In order to understand the 
mechanism by which ethanol induces cardiac muscle injury, 
reflected specifically by impaired mitochondria and loss of 
contractile elements as described, much attention to the 
effects of ethanol on myocardial protein synthesis and 
degradation is needed.
1.9 Aims of This Investigation
The subject of alcoholic cardiomyopathy has develop­
ed into a very active field of investigation in the past 
decade. Pathogenesis of this disease has relied heavily 
on observations from one or two rather dated studies on the 
myocardium of chronic alcoholic patients. These studies 
have shown gross ultrastructural abnormalities, tissue 
necrosis and fibrosis, triglyceride accumulation, and an 
imbalance in electrolyte composition resulting in loss of 
cardiac function and contractile performance.
More recently, similar observations have been made
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in studies with dogs, monkeys, rats and mice treated with 
ethanol. The value of such 'controlled' studies with 
laboratory animals is evident, for uncertainty of alcohol 
intake and nutritional status as well as the possibilities 
of heart disease from other sources in the human population 
have complicated the interpretations of the direct effects 
alcohol has on the heart.
It is the aim of this research to establish a 'con­
trolled' experimental protocol for studying the biochemical 
pathogenesis of alcoholic cardiomyopathy. The rat has been 
chosen for these experiments for practical as well as 
economic reasons.
Ethanol administered to the rats on a 24-hour basis 
as an aqueous solution provides 35-40% of their total 
caloric dietary intake. This amount of ethanol is not an 
arbitrary figure but rather simulates the nutritional state 
of a large human alcoholic population (Regan et al., 1975; 
Neville et al. , 1968) and similar quantities were 
necessary to show pronounced myocardial changes in the 
studies with laboratory animals (Segal et al., 1975; Porta 
& Gomez-Dumm, 1968). Research into the effects of ethanol is 
tied to the use of isocaloric control experiments. A 
control group, under strict dietary control was maintained 
for this purpose.
The maintenance of the level of ethanol in the blood 
is of importance throughout the duration of ethanol treat­
ment to ensure that consistent predetermined moderate 
levels prevail. This investigation will include a gas- 
liquid chromatography system for measuring and recording
blood ethanol concentrations.
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Investigations using electron microscopy will 
establish the changes in the ultrastructure of the myocar­
dium associated with chronic ethanol treatment. This work 
will be of considerable importance for determining whether 
the alcohol-fed rat really makes a suitable animal mode 
for study of alcoholic cardiomyopathy.
The ubiquitous role of the mitochondria in the 
pathogenesis of alcoholic cardiomyopathy is without doubt 
of major concern in this research. One aspect of this 
problem is illustrated by the defective respiratory func­
tions of the heart mitochondria induced by alcohol feeding. 
The respiratory integrity of isolated mitochondria from 
ethanol-treated and control rat hearts are evaluated from 
measurements of oxygen uptake using a variety of metabolic 
substrates.
It is clear that changes in fatty acid metabolism 
could affect cardiac performance through inhibition of 
fatty acid oxidation and enhancement of esterification. 
Triglyceride accumulation, therefore, is also intimately 
tied to mitochondrial function. Another aspect of this in­
vestigation deals with the measurements of the activities 
of a number of enzymes of myocardial lipid metabolism.
This entails the study of the enzymes involved in fatty 
acid 'activation' and transfer, and the intra-mitochondrial 
enzymes of 3-oxidation.
It is possible that the alcohol-induced accumula­
tion of triglyceride is an adaptive mechanism of decreased 
fatty acid oxidation. On the other hand, it may be that 
mitochondrial damage due to a direct toxic effect of alco­
hol is responsible for an overall impairment ol
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fatty acid oxidation.
It is with the hope of pinpointing the type and
location of mitochondrial damage induced by chronic and
excessive abuse of alcohol that studies of mitochondrial
protein turnover have been initiated in this investigation.
The work here will serve to design a system using polyacryl-
3amide gel electrophoresis and 1 11-leucine lo search for 
differences in the profile of mitochondrial proteins.
Total mitochondrial proteins as well as the synthesis in 
vivo of these proteins will be 'fingerprinted' on the gels. 
Future investigations examine not only the rates of protein 
synthesis but also the rate of protein degradation. If 
mitochondrial protein turnover rates are altered by ethanol, 
then further work with the system designed for this work 
will be needed to identify the alterations in sub- 
mitochondrial fractions.
3 6 .
CHAPTER 2
MATERIALS AND METHODS
2.1 Chemicals
All of the enzymes, coenzymes, substrates, salts, 
detergents, and fine chemicals used were obtained from 
Boehringer-Mannheim Corp. Ltd. (London, England), Calbio- 
chem Pty. Ltd. (Sydney, Australia), Ajax Chemicals 
(Sydney, Australia), and Sigma Chemical Co. (St. Louis,
MO), unless otherwise indicated.
Organic solvents of analytical grade were used and 
were purchased from May and Baker Ltd. (London, England), 
British Drug House Ltd. (Poole, England), and E. Merck 
(Darmstadt, Germany).
3(4,5- H)-Leucine (170 Ci/mmole) was obtained from 
the Radiochemical Centre, Amersham (Bucks, England).
Acrylamide, N ,N-methylenebisacrylamide, and tetra- 
methylethylenediamine (TEMED) was obtained from Eastman 
Kodak Co. (Rochester, NY) or Bio-Rad Laboratories (Richmond, 
CA). Ammonium persulfate was from Mallinkrodt Chemical 
Works (St. Louis, MO).
Glass distilled water was used to prepare all 
solutions. For the preparation of particular solutions 
used in protein electrophoresis high purity, double dis­
tilled water from all glass apparatus was used.
2.2 Animals and Diet
Male, Wistar rats, nine weeks old, weighing an 
average of 250 grams were used in all experiments. The
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animals were randomly divided into two groups: Group E -
those receiving ethanol for up to 120 days, and Group C - 
those maintained without ethanol for the same period, 
serving as controls.
Two series of experiments designated 60 and 120 
days were carried out on each group. Unless otherwise 
indicated, the animals were housed (three per cage) in a 
temperature-controlled animal room maintained at 22°. 
Lighting was programmed for a 12 hour light/dark cycle 
commencing at 8 a.m.
In order to determine the fraction of the daily 
total caloric intake provided by the various ethanol 
solutions, rats were divided into respective groups and 
housed individually in metabolic cages (Tecniplast, Code 
#1700). Food and liquid consumption were measured daily 
and the animal weights were determined weekly. Both 
groups received chow (Fidelity Feeds, Bunge Pty. Ltd., 
Melbourne, Australia) which provided the standard 
nutritional requirements for laboratory rats (Clark, 1977) 
Group E was fed ad libitum and ethanol was supplied as 
10, 20, and 25% aqueous solutions, as the sole source of 
liquid. Control animals were fed ad libitum for 8-9 weeks 
In comparison with ethanol-treated animals significant 
weight gain was noted for those animals on the ethanol- 
free diet. As a consequence of the above, sufficient food 
only was supplied to maintain control animals at similar 
weights to the ethanol-treated group. For details of 
alcohol and dietary regiments, refer to Figure 3.1.
Sucrose was not used to disguise the taste of
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ethanol or as an isocaloric replacement for ethanol in the 
drinking water of control animals as it may in itself have 
an effect on lipid metabolism (Pennington et al. , 1977; 
Abdulla et al. , 1980).
2.3 Estimation of Blood Ethanol Concentrations
Blood alcohol levels were monitored fröm ethanol- 
treated animals 7, 35, 60, 90 and 120 days after the 
commencement of ethanol treatment. The blood samples were 
taken at the same time of day (8.30 a.m.) and were drawn 
from the tail vein of the test animals.
Ten microliters of blood from each animal were 
collected in 1.0 ml Eppendorf tubes at 0°. The Eppendorf 
tubes were 'pretreated' by coating with the anticoagulant 
ammonium oxalate. For 'pretreatment', each tube was 
filled with 50 pi of anticoagulant (containing 0.02 mg 
ammonium oxalate) and placed in a 45° oven until the liquid 
evaporated. The tubes were covered and stored overnight 
at 0°.
The 10 pi blood samples were diluted 4-fold with 
0.1% aqueous isopropanol which served as an internal ana­
lytical standard. After centrifugation for 4 min. in an 
Eppendorf microfuge (15,000 xg) the supernatant solution 
was removed for gas-liquid chromatographic analysis of 
ethanol. Two microliter samples were injected into a Pye 
Series 104 gas chromatograph fitted with flame ionization 
detector. The glass column (1.65m x 4mm,i.d.) was packed 
with Porapak Type Q (Waters Associated, Inc., Milford, 
Mass.) to within 8.0 cm of the sample injector end and 
further packed with glass wool to 3.5 cm of the injector
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end. It was imperative to have at least 4.0 cm of glass 
wool at the injector end of the column in order to retain 
the residue of thermally denatured material from the in­
jected sample. The optimal operating conditions for the 
gas chromatograph were: column temperature 170°; injec­
tor temperature 180°; detector temperature 165°; carrier 
gas (Ng) flow 40 ml/min. Hydrogen and air pressures were 
set at optimal conditions for a hydrogen flame. Peak 
areas were determined with a Spectra-Physics SP-4100 com­
puting integrator.
2.4 Isolation of Mitochondria
Mitochondria were prepared from the hearts of in­
dividual rats using a modification of the procedure used 
by Chance and Hagihara (1961), and Vercesi, Reynafarje, 
and Lehninger (1978). The proteolytic enzyme Nagarse, 
prepared from the bacteria B. subtilis (Sigma, Type VII) 
was used in all mitochondrial preparations. All steps in 
the mitochondrial isolation were carried out at 0-4°.
In all experiments rats of the ethanol group had their 
liquid replaced by water 18 hours before death. The 
animals were fasted for 18 hours, killed by cervical dis­
location and the hearts were rapidly removed and chilled 
in (10 ml/heart) ice cold 0.25 M Sucrose. Hearts were 
washed free of excess blood and remaining tissue was quick­
ly trimmed off. The hearts were placed in (1.0 ml/heart) 
an isolation medium consisting of 0.25 M Sucrose, 0.5 mM 
EGTA, and 3.0 mM-Hepes, pH 7.4; and they were finely 
minced using ice cold sharp scissors. The minced heart 
suspension was diluted 10-fold with the isolation medium
4 0 .
to which 0.1 mg/ml of Nagarse had been added. After a 15 
min. incubation with occasional stirring, the isolation 
medium was decanted and the tissue washed twice with iso­
lation medium to remove the excess Nagarse. Isolation 
medium (10 ml/heart) containing 0.1% bovine serum albumin 
(BSA) was added to the tissue and the suspension transfer­
red to the mortar of a Potter-Elvehjem tissue homogenizer 
(size C, A.H. Thomas Co.) and homogenized gently (2 
strokes, 20 secs, each) using a loose-fitting teflon pes­
tle (clearance 0.60 mm) motor driven at 400 revs./min. 
Homogenization was continued using a 'tight' fitting pes­
tle (clearance 0.20 mm) for 2-3 additional strokes until 
minimal resistance was felt.
The heart homogenate was centrifuged at 600 xg for 
5 min. in the SS-34 rotor of a Sorvall RC2-B refrigerated 
centrifuge. The supernatant suspension was removed by 
decantation, put aside, and the resulting pellet resuspen­
ded in 10 ml isolation medium containing 0.1% BSA and the 
centrifugation repeated. The combined supernatant suspen­
sion from these 'low speed' preparations was recentrifuged 
at 600 xg for 10 min. to ensure complete removal of blood 
and cellular debris. Mitochondria were sedimented by 
centrifuging the above supernatant solution at 10,000 xg 
for 10 min. The resulting pellet was resuspended in 5 ml 
of isolation medium containing 0.1% BSA and centrifuged at 
12,000 xg for 10 min. The final pellet was washed three 
times with 0.25 M Sucrose to remove the white fluffy layer 
and finally suspended in 0.25 M Sucrose to provide a sus­
pension which contained 20 mg protein/ml. The prepar­
ation yielded approximately 6-8 mg of mitochondrial protein
per heart.
2.5 Protein Determination
Mitochondrial protein concentration was measured 
by the method of Lowry et al. (1951). Crystalline bovine
serum albumin, Fraction V, was used as a standard.
2.6 Preparation of Fatty Acid Free BSA
Treatment of crystalline bovine serum albumin, 
Fraction V, with charcoal at a pH of 3.0 by the method of 
Chen (1967), was used to obtain bovine serum albumin which 
was free of bound fatty acids.
2.7 Mitochondrial Respiration
Respiration studies were conducted within the 
first hour of mitochondrial isolation. A Clark-type oxy­
gen electrode, with temperature jacketed, 6.0 ml capacity 
chamber (Rank Bros., Oxford, England) was used for all 
experiments. Respiration was measured at 25° in an incu­
bation medium (final volume 2.0 ml) consisting of 130 mM 
KC1, 0.5 mM malate, 10.0 mM phosphate, 3.0 mM Hepes, pH 
7.4, and one of three substrate mixtures. The substrate 
mixtures employed in the incubation mixture were either 
pyruvate (5.0 mM) plus malate (1.5 mM); palmitoyl-CoA 
(50 pM) plus DL-carnitine (5.0 mM); or palmitoylcarnitine 
(50 pM). Fat. ty acid free bovine serum (50 pM) was also 
present in the incubation medium when long chain fatty 
acids were used as the substrates.
After temperature equilibration of the incubation 
medium for 2-3 min., 0.1 ml of the mitochondrial suspension
containing 2.0 mg of protein was added to 1.9 ml of the
incubation medium in the electrode chamber. Continuous
stirring of the suspension within the chamber using a
small (2.0 cm x 1 cm) magnetically driven stirring bar
guaranteed the uniformity of mitochondrial dispersion.
Adenosine diphosphate (ADP)-stimulated respiration rates
(state 3) were measured following the addition of 10 pi of
24 mM ADP. ADP-independent respiration rates (state 4)
were measured in the absence of ADP in the chamber. The 
state 3ratio of  ^ was calculated and represents the Res­
piratory Control Ratio (RCR), a sensitive indicator of 
coupled mitochondrial oxygen consumption (Chance & Wi11iams, 1956). 
The respiratory quotient (Q02 : oxygen consumption during
the phosphorylation of ADP expressed as ng-atoms of 09 
consumed min  ^ mg  ^ protein) was calculated using the 
method of Estabrook (1967). AT 25°, the quantity of dis­
solved oxygen in the incubation medium was 444 ng-atoms 
02/ml.
2.8 Measurement of Enzyme Activities
All spectrophotometric determinations of enzymatic 
reaction rates were made at 25° using either a Beckman 
Acta recording spectrophotometer model MVI (Beckman Instru­
ments Inc., Fullerton CA; USA) or a Varian Techtron UV- 
VIS double beam spectrophotometer model 635 (Varian Tech­
tron Pty. Ltd., Melbourne, Australia).
Acyl-CoA synthetase (EC 6.2.1.2 and EC 6.2.1.3) 
activity was measured using the method of Beincrt p  t- a ' / . (1953) 
as modified by Hansford (1978). The reaction mixture 
(final volume 2.0 ml) consisted of 50 mM Tris-HCl, pH 8.0;
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40 mM KCl; 0.06% (w/v) Triton X-100; 3.8 mM ATP; 7.5 mM
MgClgi oligomycin (10 pg/ml); 0.75 mM CoA; 15 mM phos-
phocreatine; adenylate kinase (12 pg/ml); creatine kinase 
(0.5 mg/ml); and 0.2 M hydroxylamine, pH 8.0. 50 pi of
mitochondrial suspension (containing 0.8 mg of mitochon­
drial protein) was mixed with 1.85 ml of the reaction mix­
ture and after 2 min. the reaction was initiated by the 
addition of 0.1 ml of 0.15 M potassium octanoate, pH 8.0. 
After 10, 20, and 30 min. intervals 0.5 ml portions of the 
incubation mixture were removed and added to 0.5 ml of ice 
cold 2.5% (w/v) FeCl3 in 0.5 M HC1. The sample tubes 
remained on ice for 10 tnin. and were then centrifuged at 
12,000 xg for 15 min. The absorbance of the ferric com­
plex of octanohydroxainic acid was read at 540 nm using 
0.8 ml samples of the supernatant solution. The activity 
of the enzyme was calculated using the molar extinction 
coefficient of 975 cm LM  ^ (Berg, 1962). Control incuba­
tions consisting of all of the above ingredients except 
the potassium octanoate accompanied each set of assays.
Carnitine acetyltransferase (EC 2.3.1.7) activity 
was measured using the method of Chase (1969). The reac­
tion mixture (final volume 1.0 ml) consisted of a solution 
which was 0.1 M Tris-HCl, pH 8.0; 0.25 mM EGTA; 20 mM
potassium malate, pH 8.0; 0.25 mM NAD+; rotenone (2.5
pg); 1.0 mM CoA; malate dehydrogenase (25 pg/ml); 
citrate synthase (50 pg/ml); and 0.04% Triton X-100.
10 pi of mitochondrial suspension (containing approximately 
20 pg of mitochondrial protein) was mixed with 0.9 ml of 
the reaction mixture and after 2 min. the reaction was 
initiated by the addition of 0.1 ml of 50 pM acetyl
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DL-carnitine. The reduction of NAD+ was followed at 340 nm 
and the activity of the enzyme was calculated using the 
molar extinction coefficient of 6220 cm  ^ (Kornberg & 
Horecker, 1955 ) .
Carnitine palmitoyltransferase (EC 2.3.1.22) ac­
tivity was measured using the method of Hansford (1978).
The reaction mixture (final volume 0.85 ml) consisted of a 
solution which was 0.1 M Tris-HCl, pH 7.8; 0.25 mM EGTA;
12 mM DL-carnitine; 0.05% (w/v) Triton X-100; and 0.12
mM - 5,5-dithiobis (2-nitrobenzoate ) . 10 y1 of mitochon­
drial suspension (containing approximately 20 pig of mito­
chondrial protein) was mixed with 0.75 ml of the reaction 
mixture and after 2 min. the reaction was initiated by the 
addition of 0.1 ml of 1.0 mM palmitoy1-CoA. The release 
of CoA-SH from palmitoy1-CoA was recorded by following the 
increase in absorbance at 412 nm. The activity of the 
enzyme was calculated using the molar extinction coeffic­
ient of 13,600 cm Hi  ^ (Ellman, 1959). Control incubations 
consisting of all the above reactants except palmitoy1-CoA 
accompanied each set of assays and the non-specific rates 
were subtracted from that of the complete reaction mixture.
Acyl-CoA dehydrogenase (EC 1.3.99.3) activity was 
measured using the method of Hoskins (1969) as modified by 
Hansford (1978). The reaction mixture (final volume 1.0 
ml) consisted of a solution which was 0.12 M potassium 
phosphate, pH 6.8; 0.05% Triton X-100; 1.0 mM KCN; 80
yM 2,6-dichlorophenolindophenol; and 0.5 piM phenazine 
methosulfate. 10 yl of mitochondrial suspension (contain­
ing approximately 20 yg of mitochondrial protein) was
mixed with 0.9 ml of the reaction mixture and after 2 min.
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the reaction was initiated by the addition of 0.1 ml ol
1.0 yM palmitoy1-CoA. As the 2,6-dichlorophenolindophenol 
was reduced by the reaction the decrease in the absorbance 
at 600 nm was recorded. The activity of the enzyme was 
calculated using the molar extinction coefficient of
21.000 cm-^M  ^ (Armstrong, 1964). Control incubations con­
taining all of the above ingredients except the palmitoyl- 
CoA accompanied each set of assays.
Enoyl-CoA hydratase (EC 4.2.1.17) activity was 
measured using the method of Stern (1955) as modified by Fong 
& Schulz (1978). The reaction mixture (final volume 1.0 ml) 
consisted of a solution which was 0.12 M Tr.is-HCl, pH 8.0; 
1.5 yM bovine serum albumin; 0.06% Triton X-100; and 
40 yM crotony1-S-CoA. The reaction was initiated by mix­
ing 10 yl of mitochondrial suspension (containing approx­
imately 1.0 yg of mitochondrial protein) with 1.0 ml of 
the reaction mixture. The rate of hydration was determin­
ed by recording the decrease in absorbance at 263 nm.
Crotony1-S-CoA has a characteristic absorption at 263 nm 
due to the diene conjugation between the a, ß double bond 
and the carbonyl double bond. An amount of adenylic acid 
(15 yg/ml) which gives an initial reading of 0.5-0.7 
absorbance was added to the control cell in place of 
crotony1-CoA to compensate for the absorption of the 
adenine moiety of crotony1-S-CoA at 263 nm. Otherwise the 
control incubations contained all of the above ingredients 
except crotony1-S-CoA. The molar extinction coefficient of 
6700 cm Hi  ^ was used in calculating the enzyme activity 
(Stern, 1955).
3-Hydroxyacy1-CoA dehydrogenase (EC 1.1.1.35)
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activity was measured using the method of Hansford (1978). 
The reaction mixture (final volume 0.95 ml) consisted of a 
solution which was 12.5 mM sodium pyrophosphate, pH 7.3;
0.05% (w/v) Triton X-100; 2.7 mM KCN, pH 7.7; 0.2 mM
NADH; and rotenone (2.5 yg/ml). 10 yl of mitochondrial 
suspension (containing approximately 2.0 yg of mitochon­
drial protein) was mixed with 0.85 ml of the reaction mix­
ture and after 2 min. the reaction was initiated by the 
addition of 0.1 ml of 1.0 yM acetoacety1-CoA. As the NADH 
was oxidized to NAD+ by acetoacety1-CoA formation the 
change in absorbance at 340 nm was recorded and the activ­
ity of the enzyme was calculated using the molar extinction 
coefficient of 6220 cm Hl H  Control incubations consist­
ing of all the above ingredients except the acetoacetyl- 
CoA accompanied each set of assays.
Acetoacety1-CoA thiolase (EC 2.3.1.9) activity was 
measured using the method of Fong & Schulz (1978). The 
reaction mixture (final volume 1.0 ml) consisted of a 
solution which was 0.1 M Tris-HCl, pH 8.0; 25 mM MgClg
30 mM KC1; 0.06% Triton X-100; and 0.13 mM CoA. 10 yl
of mitochondrial suspension (containing approximately 2.0 yg 
of mitochondrial protein) was mixed with 0.9 ml of the 
reaction mixture and after 2 min. the reaction was initia­
ted by the addition of 0.1 ml of 0.30 yM acetoacety1-CoA.
2 +The decrease in absorbance of the Mg -enolate complex was 
recorded at 303 nm and the activity of the enzyme was cal­
culated using the molar extinction coefficient of 18,000 
cm Hi  ^ (Fong & Schulz, 1978). Control incubations consis­
ting of all the above ingredients except the acetoacetyl- 
CoA accompanied each set of assays.
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2.9 Electron Microscopy
Heart tissue for electron microscopic examination 
was fixed by perfusing the isolated heart with the approp­
riate fixative solution. Animals were anaesthetized with 
ether and the abdomen was rapidly opened exposing the 
beating heart. Heparin (250 I.U. in Krebs-Ringer buffer) 
was injected into the posterior vena cava and 2 minutes 
later the ascending aorta was rapidly cannulated and tied.
A 15 ml quantity of Karnovsky's fixative solution (Karnovsky, 
1965) buffered with Millonic's phosphate buffer, pH 7.2 
(Millonic, 1961) was introduced at a rate of 10 ml/min.
After 45 seconds when half of the fixative had entered the 
heart, a small opening was cut into the right atrium to 
allow the fixative to drain, thus preventing engorgement 
of the heart. By the end of the perfusion (1^ minutes),
the heart had ceased beating and appeared blanched. A 1.0 
2cm section of the left ventricular myocardium was excised, 
cut into 1.0 mm thick slices and placed in 5.0 ml of the 
above fixative solution for 2 hours. After fixation with 
Karnovskyfe fixative solution the tissue was washed 2 times 
with 5 ml changes of 0.1 M phosphate buffer, pH 7.2. Each 
wash was of 20 minutes duration. The preparation was post- 
fixed with 0.1 M phosphate buffer, pH 7.2, 1% osmium 
tetroxide solution for 2 hours, followed by further thor­
ough rinsing with 0.1 M phosphate buffer, pH 7.2 as above. 
The tissue was dehydrated by separate 20 minute' treatments 
with 10 mis of acetone in the following ascending concen­
trations; 15, 30, 50, 70, and 95% and finally with 3 
changes of dry acetone. The tissue was then gradually in­
filtrated with Spurr's epoxy resin (Spurr, 1969) by passage
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through increasing concentrations of resin in dry acetone 
according to the following schedule:
1 part resin + 4 parts dry acetone
2 parts resin + 3 parts dry acetone
3 parts resin + 2 parts dry acetone
4 parts resin + 1 part dry acetone
Undiluted, freshly prepared resin
30 min.
30 min.
30 min.
30 min. 
Overnight
Infiltrated tissue pieces were flat embedded in 
small rings (1.0 mm thick x 2.0 cm i.d.) using the same 
resin as above, placed in an oven (45°) overnight and then 
transferred to a 70-80° oven for 2 or more days to harden.
Sectioning of the tissue blocks was done with a 
Reichert-Jung 0M-U4 Ultracut ultramicrotome (Selby Scien­
tific, Australia) using glass knives which were cut with 
an LKB Knifemaker, Type 7801 B (Tepson, Bolton & Co. Ltd., 
London, England). Thick sections (0.5 pm) were stained 
with toluidine blue (1% toluidine blue dissolved in 1% 
aqueous Borax) for examination with the light microscope 
and areas were selected for thin sectioning. Thin sec­
tions (0.06 pm) were collected on 3 mm copper slot grids 
(VECO, EERBEEK, Holland) which were coated with a solution 
of 0.3% Formvar dissolved in redistilled ethylene dichlor­
ide. The grids were stained for 30 min. with saturated 
uranyl acetate followed by a 20 min. stain in Reynolds 
lead citrate (Reynolds, 1963). Sections were examined 
with a Jeol JEM-100C transmission electron microscope ad­
justed to deliver an EMF of 80kV.
2.10 Assay of Total Mitochondrial Protein Synthesis
2.10.1 In Vivo Labelling of Mitochondrial Proteins
In order to determine the effects of chronic
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ethanol consumption on total mitochondrial protein synthe­
sis in vivo, ethanol-treated and control rats were inject­
ed intraperitoneally with 400 yCi of (4,5-^H)leucine.
After two hours, the heart mitochondria were prepared as 
described in Section 2.4, with the following modifications. 
The isolation medium used to prepare ^H-leucine labelled 
mitochondria consisted of 0.25 M Sucrose, 0.5 mM EGTA, 3.0 
mM-Hepes, pH 7.3, and 0.5% unlabelled leucine. At no time 
during the isolation procedure was bovine serum albumin 
included in the isolation medium. The mitochondria from 
the hearts of five rats were pooled for each experimental 
group. The final pellet was suspended in 0.25 M Sucrose 
to provide a suspension which contained 50 mg mitochondrial 
protein per ml. The preparation yielded approximately 
35-40 mg of mitochondrial protein.
2.10.2 Determination of ^H-leucine Incorporation
For each experimental group, 0.6 ml of the mito­
chondrial suspension (containing approximately 30 mg of 
mitochondrial protein) was precipitated with 30 ml of 10% 
TCA solution and recovered by centrifugation at 12,000xg 
for 15 minutes, using an SS-34 rotor in a Sorvall RC-2B 
refrigerated centrifuge. The pellet was washed three 
times with an ice cold 5% TCA solution containing 0.5% un­
labelled leucine. Each wash was of 15 minutes duration.
The pel lei was then dissolved in 3.0 ml of 1.0 M NaOIl and 
a 0.1 ml sample was taken for the determination of protein. 
Duplicate samples of 0.1 ml were added to 4.0 ml of a 
solution for the determination of radioactivity using 
liquid scintillation counting. The scintillant contained
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1200 ml toluene, 160 g naphthalene, 12 g butyl-PBD, and 
800 ml methoxyethanol. The background radioactivity was 
determined using duplicate control samples containing 0.1 
ml of 1.0 M NaOH in 4.0 ml of the above solution. Radio­
activity was measured using a Beckman LS-100 Liquid 
Scintillation Counting System. The efficiency of measur­
ing radioactivity was 27%.
2.11 SDS Polyacrylamide Gel Electrophoresis of Total 
Mitochondrial Proteins
3The remainder of the H-leucine labelled mitochon­
drial protein (approximately 5 mg) was prepared for SDS 
polyacrylamide gel electrophoresis on vertical slab gels 
prepared using the methods of O'Farrell (1975) and Ames and 
Nikaido (1976). The discontinuous buffer system described 
by Laemmli (1970) was used for the resolution of the mito­
chondrial proteins under dissociating conditions.
The slab gels were prepared by pipetting the 
appropriate resolving gel and stacking gel solutions 
between 15 cm glass plates separated by 1.5 mm spacers.
The glass plates were clamped to a Vertical Slab Electro­
phoresis Cell (Bio-Rad, Model 220).
For the preparation of the appropriate gel solut­
ions, it is established that higher concentrations of the 
cross-linker N ,N-bis-acrylamide (bis) are required with 
low gel concentrations to provide mechanical strength. At 
fixed monomer (acrylamide) concentrations, higher concen­
trations of cross-linker give a smaller 'pore' size, thus 
lowering the mobility of samples during electrophoresis.
To achieve maximum gel quality a balance must be found
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between mechanical strength and reasonable pore size. 
Reliable and reproducible results were obtained using the 
following quidelines. For gels of a) 5-8% (w/v) total 
acrylamide composition, the concentration ratio of bis: 
acrylamide of 1:39 was used and for gels of b)>3% (w/v) 
total acrylamide composition a concentration ratio of bis: 
acrylamide of 1:59 was used.
Convenient 30% (w/v) acrylamide stock solutions 
(O'Farrel, 1975; Laemmli, 1970) were prepared as follows: 
a) for a concentration ratio of bis:aerylamide of 1:39, 
0.75 g of bis and 29.25 g of acrylamide were dissolved in 
100 ml of water, and b) for a concentration ratio of bis: 
acrylamide of 1:59, 0.5 g of bis and 29.5 g of acrylamide 
were dissolved in 100 ml water. These stock solutions 
were prepared with high purity water, filtered, and stored 
away from light in foil wrapped bottles at 0-4° for up to 
one month.
The gels found to give maximum resolution of 
mitochondrial proteins were a resolving mixture composed 
of 12.5% total acrylamide, and a stacking gel composed of 
5% total acrylamide. Ten 50 yl samples containing 100 yg 
of mitochondrial protein were run into the stacking gel at 
a constant voltage of 40V (initial current was 30 mA) for 
45 minutes and electrophoresis was continued at a constant 
voltage of 200 V (initial current was 125 mA) until the 
bromophenol blue' tracking dye front was 1 cm from the 
bottom of the gel, approximately 2 hours. The molecular 
weight markers bovine serum albumin (66,000) Ovalbumin 
(45,000), Pepsin (34,000), Trypsinogen (24,000) (3- 
Lactoglobulin (18,400, subunit) and lysozyme (14,300)
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were run in parallel with mitochondrial protein samples.
2.12 Treatment of SDS Polyacrylamide Gels
2.12.1 Staining
Immediately after electrophoresis, the gels were 
placed in a staining solution of methanol:acetic acid: 
water (9:2:9) containing 0.25% (w/v) Coomassie Brilliant 
Blue for 1-2 hours with continuous 'rocking' agitation.
The gels were destained with an ethanol:acetic acid:water 
(5:2:13) solution for 1-2 hours with agitation. The de- 
staining solution was replaced and the destaining process 
was continued overnight. The destaining solution may be 
replaced once more and the process continued for a further 
1-2 hours resulting in a clear gel with sharp blue stained 
protein bands. The gel was then stored in 7% acetic acid 
solution until it was further processed. At this stage, 
'densitometer' readings of the gels may be made, the gels 
may be dried for autoradiography, or the gels may be 
sliced for a direct determination of radioactivity.
2.12.2 Densitometer Trace
Densitometer tracings of the protein contents of 
the gels were made using a Transidyne 2955 Scanning Densi­
tometer (Transidyne General Corp., Ann Arbor, MI). Quan- 
tification of electrophoretic patterns of Coomassie blue 
stained protein bands, at 600 nm and autoradiographic 
banding at 700 nm, was accomplished with the Transidyne 
2967 Computing Integrator.
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2.12.3 Drying
Gels were placed on a piece of Whatmann No.1 
chromatography paper that was cut to the same shape as the 
gel drying plate of a Bio-Rad Model 224 (220V) Gel Slab 
Dryer. A suction pressure of 700 mm Hg was applied and 
complete drying of the gel took 2| hours.
2.12.4 Autoradiography
Dried gels were exposed to Kodak X-Omat S medical 
x-ray film in Kodak X-Omatic cassettes C-2 (18 x 24 cm), 
stored below 0°. After 6 weeks the films were developed 
in Kodak liquid x-ray developer solution for 10 minutes at 
22°, rinsed thoroughly and hung to air dry. The films 
were then scanned in the densitometer and the readings 
graphically traced.
2.12.5 Gel Slicing
The gels were cut vertically to separate each mito­
chondrial protein sample that had been resolved using 
electrophoresis. Each vertical strip was cut horizontally 
into 2.0 mm slices with a home-made gel slicer composed of 
75 single-edged razor blades separted by 2.0 mm metal 
spacers. Each gel slice was placed into a scintillation 
vial with 4.0 ml hydrogen peroxide and heated overnight 
at 50° or until the gel slices were completely dissolved. 
Ten milliliters of the aforementioned scintillation count­
ing solution were added and the radioactivity in each
slice was determined.
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CHAPTER 3 
RESULTS
3.1 Caloric Intake
The average daily consumption of calories as food 
and liquid for the control group and for the rats receiving 
various quantities of ethanol is given in Table 3.1. Rats 
on the 25% ethanol diet received approximately 40% of their 
total calories from ethanol, and as this quantity of 
ethanol has been employed successfully in previous studies 
on the effects of chronic alcohol consumption (Segal et al. , 
1975; Sarma et al. , 1976;. Williams and Ting-Kai, 1977; 
Pachinger et al. , 1973). A 25% aqueous ethanol solution 
therefore was adopted as the sole source of drinking fluid 
for the ethanol-treated rats over the time course of study.
The total energy consumed per day for both groups 
was approximately 60 Calories. The percentage proportions 
of dietary caloric components in the final regime consumed 
by rats of the alcohol group during the time course were 
approximately 40% from a 25% ethanol solution and 60% from 
chow. The control rats consumed 100% of their energy in­
take from chow.
It is shown, however, in the next section that 
although caloric intake may be the same for both groups, 
the control group gained weight at a faster rate than those 
receiving ethanol. An adjustment was thus necessary to 
control the amount of food that the control animals 
received in order to maintain similar body weights for both
groups.
from food and various concentrations of ethanol 
by rats maintained in metabolic cages
Table 3.1: Daily consumption of energy (Calories) derived
Two groups of rats, Group E, those receiving 10, 20, 
and 25% aqueous solutions of ethanol as sole source of liquid 
and Group C, those receiving distilled water, were fed rat 
chow ad libitum and housed individually in order to allow 
the daily measurements of food and liquid consumption. For 
the ethanol group, each solution of ethanol was administered 
for three weeks and all measurements of consumption for each 
solution commenced after a one week adjustment period. The 
adjustment period allowed the rats to adjust to the 'new' 
liquid taste and to 'learn' the physical effects resulting 
from ethanol in the diet. Similar nutritional measurements 
were made using the control group for comparative purposes. 
The energy value of the chow was taken to be 3.04 Calories/ 
gm of food, while the energy value for the 95% redistilled 
ethanol used was taken to be 6.65 Calories/gm ethanol.
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3.2 Maintenance of Isocaloric Controls
Data on the growth of animals during the time course 
are summarized in Fig. 3.1. The body weights of both groups 
of rats were the same at the start of the experiment. After 
one and two weeks, the alcoholic group showed a significant 
weight loss, presumably the result of their aversion to the 
effects and taste of ethanol. As a consequence of their 
refusal to drink their only source of liquid, consumption 
of chow also decreased. Weight loss during this adjustment 
period could be minimized by replacing the 25% ethanol 
solution with water once a week for the first two weeks.
Following the initial adjustment period, the experi­
mental group then showed an increase in weight throughout 
the remainder of the experimental period. Despite some 
increase in weight during the interval of ethanol treatment, 
it is apparent that these animals are impaired in overall 
growth. This is shown by the growth curve for untreated 
male Wistar rats of similar age receiving chow and water 
ad libitum.
Several studies on chronic alcohol consumption by 
laboratory animals have shown that throughout the period 
of ethanol administration the mean body weights of those 
animals receiving alcohol were significantly lower than 
those of the corresponding control group (Antal at al., 1979 
Lieber, 1973; Porta and Gomez-Dumm, 1968; Lieber et al. , 
1965). A possible explanation for differences in growth 
rates of ethanol-treated animals receiving sufficient 
calories, involves the theory of 'empty calorics' provided 
by ethanol. It has been suggested, that during the metab­
olism of ethanol by the microsomes and endoplasmic
• i»
:li
Fig. 3.1: The time course of weight increase of male Wis-
tar rats fed rat chow ad libitum compared with
rats on a controlled food rat ion and rats given
40% of their total energy requirements as 25%
ethanol and remaining 60% as rat chow.
Animals receiving the 25% ethanol solution and those 
that served as controls were weighed once a week for the 
first nine weeks followed by periodic weight checks for the 
duration of the time course. Rats in the ethanol group were 
retarded in growth during the first week and their body 
weights throughout the following three weeks remained 
significantly lower than the control group. In order to 
maintain similar weights of the two animal groups, the amount 
of chow given to the control animals at four weeks was 
decreased to 18.0 gm (54 Cal/day) and at seven weeks was 
reduced to 16.0 gm (48 Cal/day). Also included for compara­
tive purposes is the growth rate for male Wistar rats fed 
chow and water ad libitum. Animal weights (gm) are 
expressed as the mean value, and the number of animals 
weighed in each group was 12.
Ethanol treated group
Control group
Normal {ad libitum) group
Day« of Treatment
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reticulum of the liver, much of the energy produced is 
liberated as heat and is not converted to chemical energy 
as in normal metabolic oxidations (Lieber, 1973; Lundquist 
1975) .
In this study, because of the undesirability of 
providing control animals with an isocaloric replacement 
of sucrose for ethanol, another method for maintaining iso­
caloric controls was adopted. Using the mean weight of the 
ethanol-treated animals as a parameter, the amount of food 
consumed by the control animals was restricted, as des­
cribed in the legend of Fig. 3.1. This manipulation 
resulted in the achievement of similar weights for the two 
groups at the critical times during the time course when 
the animals were sacrificed for study. It is believed 
that this method provides a 'true’ method for the mainten­
ance of isocaloric control, since the animals each receive 
equal quantities of 'useful' calories.
Vitamin supplements were not included in the diet 
of ethanol-treated rats because of the desire to avoid 
further unnecessary variables. It has been shown that aug­
mented vitamin intake to prevent the possibility of 
nutritional deficiencies in rats receiving large doses of 
ethanol offered limited protection against the pathogenesis 
of alcohol-related diseases (Segal et at., 1975; Abe et 
al. , 1979; Dubroff et al., 1979; Eriksson et al., 1980).
The possibility of employing a liquid diet for 
studies of chronic ethanol consumption was considered, but 
due l.o inconvenience, expense and cogent biochemical 
reasons discussed in the next chapter, the idea was abandon 
ed.
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Throughout the time course of the experiment, less 
than 10% of the animals from both ethanol-treated and 
control groups died or had to be killed. The deaths which 
did occur resulted from sawdust inhalation or middle-ear 
infections and were not directly related to the dietary 
regimen employed.
3.3 Blood Ethanol Concentrations
Figure 3.2 shows that over the 120 day period, the 
ethanol concentration in the blood of ethanol-treated rats 
ranged from 192 mg % to 95 mg %. Blood ethanol levels 
remained elevated throughout the time and stabilized by 90 
days at 95 mg % (Fig. 1). The stabilized level was the 
lowest concentration of ethanol detected in the blood 
throughout the time course and may indicate an increased 
capacity of the rat to metabolize ethanol. Although the 
blood ethanol concentration dropped to 95 mg %, it consis­
tently remained above the 80 mg % concentration proposed as 
the intoxicating concentration for the human (Krebs, 1968).
If ethanol metabolism in the rat is enhanced after 
several weeks of exposure to this agent, it would support 
the concept of 'adaptation' put forward from the results of 
numerous metabolic changes in the rat noted by Lochner et 
al. (1969) over a prolonged period of ethanol treatment.
It has also been shown that humans have the capacity for 
enhanced ethanol metabolism (Regan ct al., 1975). The* 
adaptive similarities for both systems provides support for 
the use of the rat as an experimental model for alcohol-
related diseases.
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Fig. 3.2: Changes in the concentration of the blood
alcohoT during the 120 day ethanol treatment 
of rats
Blood samples from rats receiving a 25% aqueous 
ethanol solution as the sole source of drinking fluid were 
used for the determination of ethanol concentrations in 
the blood. Samples were obtained from the tail vein of the 
rats 7, 35, 60, 90 and 120 days after commencement of 
treatment. Protocols for the preparation of samples and 
gas-liquid chromatographic analysis using 0.01% isopropanol 
as internal analytical standard are given in Sec. 2.3. 
Concentrations are expressed as mgs ethanol/100 ml blood 
(mg %). Results are expressed as mean values ± S.E.M. The 
number of samples arc given in parenthesis.
Days of Ethanol Treatment
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3.4 Studies of Mitochondrial Respiratory Function
Table 3.2 presents the results of the oxygen con­
sumption by mitochondria with the substrates pyruvate plus 
malate, palmitoy1-CoA plus carnitine and palmitoylcarnitine. 
It was seen that when pyruvate plus malate were used as 
substrates, there was depressed respiratory activity of the 
mitochondria from the hearts of ethanol-treated rats com­
pared to controls following both 60 and 120 day periods of 
alcohol feeding. There was a depression in State 3 respir­
ation expressed as QOg in all alcoholic animals when 
pyruvate was utilized, and phosphorylation coupling, as 
judged by the respiratory control ratios (RCR), was depres­
sed in the ethanol-treated groups. Although these results 
provide evidence of an ethanol-induced lowering of the 
values of the respiratory function, the ability of the 
mitochondria to oxidize pyruvate plus malate from control 
and ethanol-treated animals throughout the time course was 
not statistically significant (P > 0.05).
In addition to pyruvate oxidation, results are 
presented in Table 3.2 of two other substrate combinations, 
palmitoy1-CoA plus carnitine and palmitoylcarnitine. Both 
of these fatty acid substrates require the carnitine:acyl- 
carnitine exchange carrier of the mitochondria for oxidation 
(Fig. 1.2). The oxidation of palmitoy1-CoA plus carnitine 
differs from that of palmitoylcarnitine only in that it 
requires the' action of the palmitoy lcarni t i ne transferase 
enzyme external to the permeability barrier of the inner 
mitochondrial membrane (Fig. 1.2). The lower rate of oxy­
gen consumption with palmitoy1-CoA plus carnitine in all 
experimental groups suggests that the external acyl
Table 3.2: Changes in the respiratory control ratios (ItCR)
a n d r a t e s  o f  O 2 u p t a k e ( Q O 2 ) b y  m i t o c h o n d r i a
i s o l a t e d  f r o m  t h e  h e a r t s  of e t h a n o l - t r e a t e d
a n d c o n t r o l  r a t s  at  6 0 a n d  1 2 0  d a y s  o f  t r e a t -
ment
Mitochondria (2.0 mg of protein) were added to 1.9 
ml of air-saturated incubation medium containing one of the 
substrate combinations given in Section 2.7. The composit­
ion of the incubation medium was 0.13 M KC1, 3.0 mM Hepes, 
and 10 mM potassium phosphate, pH 7.3; further details are 
given in Section 2.7. Oxygen consumption was measured with 
an oxygen electrode at 25° in the presence of added (120 pM) 
ADP (State 3) and after depletion of the ADP (State 4) by 
mitochondria. Respiratory control ratios (RCR) are ex­
pressed as the rate of O2 consumption during State 3/rale of 
O2 consumption during State 4. Rates of 02 uptake (QO2 ) 
were measured during phosphorylation of added ADP (State 3) 
and are expressed in ng-atoms of 0 min-l mg_l of protein. 
Results are presented as the mean values t S.E.M. with the 
number of mitochondrial preparations given in parenthesis. 
Statistical significance was evaluated by Student's t test: 
N.S., not significant (P > 0.05).
W  M  
r r  CO s § 9 § % %CP O P  o tr P 0  d3
>d Ü! £ 3 P ►d
g  S ’
0  'C
d f? 
O 'C
d CD 
di d
1—1 *< l—1 << 1—1 I—1
frt
P1—1
CO CO ►P
@ <2  
•—1 3CD f455
00
05
✓—s 2 55
05
CD/^ N
b
g
GO
Ü1 14- Ü1 14-
GO ü l  14-V—s
O l 14- s C-4 <; 
CD P
CO CJ1 CO CO
c+
(X)o M M O
• /—s
cn cn
M M CO CO o
CO cn o CO
CO CO o ds
5! b CO 55 <1 M 6
i—1
d
GO 14- 14- GO 14- 14-
id 00
M
O
M
M
M
CD
CO 00 oo b
CO CO CO CO
o di 
p p
05 05 CO -o 3  3N
.S
.
00
/■----N
0 5  14-
CD/'"N
O ) 14-
.0
0
2
M  
0 5  14-
v__y
G )
O  14-
RCR H- H- r+ r f  
H- O 
P a
CO CO o M CD M  | b
CO ►P 05 CO ^  o tdcn 0 m
• D>
1H M M M
c
Cn CO CO o00 CD CO CO /-“N
55 05 O 55 b CO 8
o
cn 1
CO
14- 14-
'cn 14- 14- CO14.4
G5
CO
00
CD
cn
CO
M
d
m
CO ►P d)P
5 5
CD
CO/•"S
05
<1/"■"S 55
O
CD
S N
£
/'""N
g
td
>-Q
H *
CO
O l 14- G )  14-
GO <1 14-V___' * 0  1+ v*—y o'C
CO CO CO K
i—1 
i05 05 CO CO o
5
£3
CO CO CO CO
H *
o CO 05 cn H*oo o O cn b
p4 < i 05 55 CO CD 8CO
CD
/—N
CO 14- 14- CO 14- 14- O
M CO • M cn o<1 CO 00 cn
O M < 1
59 .
transferase enzyme is rate limiting for the entire oxidative 
pathway under these conditions.
Table 3.2 shows that throughout the time course of 
this study, the ability of isolated heart mitochondria to 
oxidize palmitoy1-CoA plus carnitine and palmitoylcarnitine 
in the presence of added ADP (QOg) from ethanol-treated 
compared to control animals was not significantly different. 
Only those animals receiving ethanol for 120 days showed a 
depression in oxygen uptake by isolated mitochondria when 
palmitoylcarnitine was substrate. This same group showed 
an increase in the rate of oxygen consumption when 
palmitoy1-CoA plus carnitine was the substrate.
With palmitoy1-CoA as substrate, phosphorylation 
coupling, as judged by respiratory control ratios was sig­
nificantly depressed in isolated heart mitochondria from 
rats receiving ethanol for 60 days (Table 3.2). This 
depressed coupling ability had returned to normal levels by 
120 days of ethanol administration suggesting an ethanol- 
induced adaptive capacity for fatty acid respiratory 
activity.
The data in Table 3.2 show that a contrast of the 
mitochondrial respiratory control values for palmitoyl- 
carnitine at 120 days of the untreated (control) and 
ethanol-treated animals indicates a depression of this value 
in the treated group. The measured decrease shows the data 
are not statistically significant although the depressed 
value is consistently noted. Since the RCR at 120 days of 
ethanol treatment is similar to the RCR for palmitoyl- 
carnitine of both control and treated animals at 60 days, 
there is no compelling reason to believe from this limited
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study that the enzymes of 3-oxidation may be a site of an 
ethanol-induced lesion. Direct measurement of the acyl- 
transferase activity as well as measurements of the enzymes 
of fatty acid 3-oxidation are reported below.
3.5 Activities of Enzymes Involved in Fatty Acid Oxidation
This section reports the results of experiments 
designed to investigate ethanol-induced changes in the 
mitochondria at the level of selected enzymes of fatty acid 
oxidation. Isolated mitochondria from ethanol-treated and 
control rats were used to measure the maximum catalytic 
capacity of several enzymes of fatty acid oxidation using 
assay conditions to optimize measurement.
Acyl-CoA synthetase activity was measured (Table 
3.3) with octanoate as substrate. This medium chain length 
fatty acid is believed to penetrate the mitochondria as 
such and does not require participation of the acyl trans­
ferase enzyme (Gilbertson, 1977). In this assay, the syn­
thetase reaction is reported to be the rate limiting step 
(Hansford, 1978).
The data of Table 3.3 show that ethanol treatment 
causes no change in the activity of acyl-CoA synthetase 
during the time course of the experiment. The acyl-CoA 
synthetase enzyme is specific for medium chain length fatty 
acids and it is localized in the mitochondrial matrix. It 
functions primarily for the activation of medium chain fatty 
acids and for their transport out of the mitochondria, per­
haps for chain elongation in fatty acid synthesis. The 
shunting of intermediates of oxidation from the intramito­
chondrial pool to the extramitochondrial pool would effect
Table 3.3: Activities of some enzymes involved in fatty 
acid oxidation by mitochondria from the hearts 
of ethanol-treated and control rats after 60 
and 120 days of treatment
Enzyme activities were measured at 25° in the 
presence of Triton X-100 to remove mitochondrial permea­
bility barriers. Conditions of assay are described in 
detail in Section 2.8. Activities are expressed in nmole 
min~l mg-1 mitochondrial protein. Results are presented as 
the mean values ± S.E.M. with the numbers of mitochondrial 
preparations given in parentheses. Statistical significance 
was evaluated by Student's t test: N.S., not significant
(P > 0.05).
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oxidative product formation, but the exact physiological 
significance is unknown (Brass and Hoppel, 1980). The 
measured activity of this enzyme does not provide informa­
tion about the capacity for activation of the long chain 
fatty acids which are the substrates that play the primary 
role in oxidative energy production. The results of the 
measured activity only show that given the optimal con­
ditions of the assay system in vitro, i.e. abundant free 
CoA-SH, then the enzyme which contributes, indeed initiates 
the primary process of fatty acid oxidation, remains un­
changed during chronic ethanol treatment. The observation 
that there was no increase in the activity of the synthe­
tase enzyme may indicate that chain elongation, which plays 
a primary role in the synthesis of long chain fatty acids 
is probably not increased. This provides some indirect 
evidence that ethanol-induced triglyceride accumulation may 
not occur by the increased synthesis and esterification of 
long chain fatty acids.
The carnitine acetyl-transferase enzyme plays a 
quite different metabolic role from that of the long chain 
fatty acyl-transferase enzyme since: a) oxidation of short
chain fatty acids is usually carnitine independent, and b) 
these fatty acids are not of quantitative importance for 
energy production inherent in muscle (Greville & Tubbs, 
1968; Oram, 1973). The acetyl-carnitine-carnitine couple 
serves to damp down rapid fluctuations of acetyl-CoA in the 
mitochondria. This "acetyl buffer" function is analogous 
to the role of phosphagens (Pearson and Tubbs, 1967).
However, the activities of this enzyme (Table 3.3) 
did not show a measurable change throughout the time course
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of ethanol treatment. The carnitine acetyl-transferase 
enzymes are held to be sufficiently active in the heart to 
maintain near equilibrium as shown by the flux through the 
reaction and the rates of consumption with acetylcarni- 
tine as substrate (Hansford, 1978). This should not, 
however, obscure an ethanol-linked decrement of activity in 
comparative studies such as the investigation reported here, 
assuming that such changes occur.
Carnitine palmitoyl transferase was the first 
enzyme measured that is involved in the metabolism of long 
chain fatty acids. Long chain fatty acids represented by 
palmitoyl-CoA, serve a major metabolic role in energy pro­
duction as discussed above. As this enzyme is located on 
both sides of the inner mitochondrial membrane (Fig. 1.2) 
the method of assay involved disruption of the mitochondria 
to allow measurement of activities both internal and ex­
ternal to the permeability barrier.
As shown in Table 3.3, there is a 25% decrease in 
the activity of this enzyme in mitochondria after 60 days 
of ethanol treatment and a 30% decrease in the activity 
after 120 days of ethanol treatment. The reason for the 
ethanol-induced decrease in activity is not known. It has 
been suggested that ethanol may exert a toxic effect on 
membrane integrity (Wendt et al., 1965; Pachinger et al., 
1973; Williams and Ting-Kai, 1977). Since the enzyme is 
intimately associated with the inner mitochondrial membrane, 
ethanol treatment may lead to an alteration in the conform­
ation of the enzyme. It is also possible that the available 
carnitine in the mitochondria could be affected by ethanol 
treatment and thus influence the activity of the
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transferase enzyme. This possibility will be discussed 
further in Section 4.4.
The acyl-CoA dehydrogenase enzyme is considered to 
be a possible rate-limiting step in the fatty acid oxi­
dation spiral (Stanley and Tubbs, 1975). Measurement of 
the activity of the enzyme (Table 3.3) showed that although 
there was an age-related increase in activity, changes due 
to ethanol treatment were not found. Despite an attempt 
to develop optimal assay conditions in vitro, acyl-CoA 
dehydrogenase activities measured with the artificial 
electron acceptor phenazine methosulfate are probably not 
representative of the physiological state nor of its 
catalytic efficiency in vivo. This should not, however, 
have obscured an ethanol-linked change in activity in the 
comparative studies reported here if it occurred.
An ethanol-induced depression of fatty acid oxidation 
may result from a concerted decrease in the activities of 
several enzymes of oxidation or may be the result of a 
toxic effect of ethanol on mitochondrial structure. Enoyl- 
CoA hydratase is not considered to be a rate-limiting 
enzyme in the oxidation process, since the activity (Table 
3.3) of this enzyme is at least one order of magnitude 
greater than the synthetase, transferase, acyl-CoA dehydrog­
enase, and thiolase enzymes. It was felt, however, that 
measurement of enoyl-CoA hydratase activity was of interest 
since a putative mitochondrial lesion which is attributed 
to ethanol treatment could effect not only the critical 
enzymes of limited activity but may influence enzymes with 
a super-abundant activity as well. The results of this 
assay shown in Table 3.3 show that there is no change in
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the activity of this enzyme throughout the time course.
The activity of 3-hydroxyacyl-CoA dehydrogenase was 
measured since it is accepted that this enzyme represents 
the capacity of the tissue to carry out 3-oxidation. 
Furthermore, as Fong and Schulz (1978) suggest, inhibition 
of any part of the 3-oxidation enzyme complex could result 
in inhibition of fatty acid oxidation. The measurement of 
the activity of 3-hydroxyacy1-CoA dehydrogenase in heart 
mitochondria from ethanol-treated and control rats during 
the time course of the study shows there is a 21% dimin­
ution in activity at 60 days in the treated group of 
animals. The disconcerting feature of this result is that 
the value obtained for the activity of the enzyme after 60 
days of ethanol treatment is similar to the activities from 
both experimental groups at 120 days. It is a feeling 
however, that were the number of preparations increased in 
the 60 day sample, there would probably be no significant 
change in the activity of this enzyme.
Finally, the activity of acetoacety1-CoA thiolase 
was measured. Measurements of the activities of this 
enzyme (Table 3.4) show that ethanol treatment causes a 
decline in activity throughout the time course. There is a 
14% diminution in activity in mitochondria from rats treat­
ed with ethanol for 60 days, and a 29% diminution in activ­
ity after 120 days of treatment.
Based on the calculations of Fong and Schulz (1978), 
one-fourth of the acetoacety1-CoA thiolase activity 
(approximately 800 nmole/min ^mg  ^ protein) in solubilized 
rat heart mitochondria is due to keto-acy1-CoA thiolase 
(Thiolase I), whereas three-fourths of the activity is due
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to acetoacety1-CoA thiolase (Thiolase II). Thiolase I is 
the enzyme required for the 3-oxidation of fatty acids, 
whereas Thiolase II functions in ketone body degradation.
Of great importance to a full understanding of the regula­
tion of 3-oxidation is the possible cooperation of 
Thiolase I and II which if effective would assure a high 
rate of degradation to acetyl-CoA of all 3-ketoacy1-CoA 
compounds formed during fatty acid oxidation.
A depression in the activity of either of these 
enzymes as a result of ethanol treatment would clearly 
contribute to inefficient fatty acid oxidation. This assay, 
however, measures primarily the activity of acetoacetyl-CoA 
thiolase which catalyzes the final step of the complete 
oxidation of fatty acids to acetyl-CoA. It is possible 
that this enzyme has an important regulatory function 
associated with controlling the fate of acetyl-CoA in res­
ponse to the metabolic needs of the heart.
3.6. Pathological Studies of Experimental Alcoholic 
Cardiomyopathy
3.6.1 Gross Examination
The gross appearance of the hearts of all alcoholic 
rats was similar to those of the control rats. The hearts 
were uniformly red-brown and showed no evidence of 
specific chamber dilation. The weights of the hearts were 
not significantly different and are given as the mean in 
grams per 100 g of body weight 1 S.E.M.: 60 Day Control
(.2621.0085); 60 Day Ethanol-treated (.2541.0074); 120
Day Control (.2621.0060); 120 Day Ethanol-treated (.2471.0020).
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3.6.2 Light Microscope Studies
For light microscope examination, sections of left 
ventricular myocardium from each experimental group of 
animals were cut to show both longitudinal and transverse 
myofiber orientation. The myocardium appeared similar for 
ethanol-treated and control rats at 60 and 120 days of 
treatment. In longitudinal sections striation of the fibers 
was obvious due to the subdivision of the myofibers into 
fascicles by rows of mitochondria. Transverse sections 
showed the numerous capillaries present in cardiac tissue. 
Mitochondria were numerous and several cell nuclei were 
apparent (Figs. 3.3, 3.4, 3.5). No vacuolization, inter­
stitial edema or myofibrillar fibrosis could be discerned 
in sections of the left ventricle from rats receiving 
ethanol.
3.6.3 Electron Microscope Studies
U1trastructural examination revealed that the myo­
cardium of ethanol-treated rats was indistinguishable from 
that of control rats throughout the time course, and 
appeared as reported for mammalian cardiac muscle (Moore 
and Ruska, 1957) (Figs. 3.6, 3.7, 3.8, 3.9, 3.10, 3.11, 3.12, 
3.13). Myofibril bands showing the characteristic pattern 
of cross-striation alternated with rows of mitochondria.
At fairly regular intervals along the length of the fibers 
the intercalated disc appeared as heavy transverse lines. 
Glycogen granules and lipid droplets were present in the 
interstitium.
The mitochondria were numerous in all of the tissue 
sections examined, and no significant increases in the
Fig. 3.3: LM-Myocardium from control rat (120 days)
Longitudinal section passing through several myo- 
fibers of the left ventricle. Bands of cross striation are 
apparent in the myofibers which alternate with rows of 
dark staining mitochondria (x 800).
Fig. 3.4: LM-Myocardium from control rat (120 days)
Transverse section passing through several myo­
fibers of the left ventricle. There are numerous dark 
staining mitochondria within each cell and several light 
staining nuclei are apparent. Many capillaries can be seen, 
several containing red blood cells (x 800).
Fig. 3.5: LM-Myocardium from ethanol-treated rat (120 days)
Section of the left ventricle showing both longi­
tudinal and transverse orientations of the myofibers. The 
muscle tissue appears unchanged at this magnification. The 
longitudinal area shows a normal pattern of myofibrillar 
striation and numerous dark staining mitochondria are present 
in the sarcoplasm. The transverse area shows several 
capillaries which may contain red blood cells (x 800).

Fig. 3.6: EM-Myocardium from control rat (120 days)
Representative longitudinal section of left ventric­
ular myocardium showing the normal distribution of mito­
chondria (M) which alternate with the myofibers (Mf). The 
myofibers are divided into sarcomeres by dense Z bands (z). 
In the center of each sarcomere is the H zone (h). The 
intercalated disc (ID) may be seen at various intervals 
along the myofiber. Glycogen granules (g) and lipid drop­
lets (L) are present inthe sarcoplasm (Sa). Interstitial 
space, (In); Nucleus, (N); (x 6500).
Fig. 3.7: EM-Myocardium from control rat (120 days)
Note the tightly packed filaments of the myofiber 
(Mf) and the presence of dense Z contraction bands (z) 
Mitochondria (M) show double membrane and dense, tightly 
packed cristae. Dark staining, osmiophilic lipid droplets 
(L) are surrounded by mitochondria. Glycogen granules (g) 
and elements of the sarcoplasmic reticulum (SR) are 
present. (x 50,000).

Fig. 3.8: EM-Myocardium of ethanol-treated rat (120 days)
Representative longitudinal section of left ventric­
ular myocardium showing normal distribution of mitochondria 
(M) and myofibers throughout the cell including the area 
near a capillary (Ca). There is no evidence of fiber 
degeneration and normal pattern of striation of Z band (z) 
and H band (h) of the sarcomere can be seen. Lipid drop­
lets (L) and glycogen granules (g) are present in the 
sarcoplasm (Sa). Lipid droplets (L) appear as dark stain­
ing osmiophilic deposits and as light opaque deposits (L) 
(arrow). Interstitial space, (In) (x 6500).
Fig. 3.9: EM-Myocardium of ethanol-treated rat (120 days)
The mitochondria (M) surrounded by the characteris­
tic double membrane appear normal. The cristae are tightly 
packed and show no evidence of degeneration. The myofiber 
(Mf) shows a continuous Z contraction band (z). Elements of 
the sarcoplasmic reticulum (SR) can be seen. (50,000).
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Fig. 3.10: EM-Myocardium of control rat (120 days)
Representative transverse section through left 
ventricular myocardium. Muscle cells are separated by 
the interstitial space (In). A lipid droplet (L) and a 
portion of the nucleus are present within the cell. Red 
blood cells (rbc) may be present within the capillaries 
(Ca). (x 3250).
Fig. 3.11: EM-Myocardium of ethanol-treated rat (120 days)
Representative transverse section through left 
ventricular myocardium appears unchanged by ethanol treat­
ment. The muscle cells are separated by the interstitial 
space (In). Lipid droplets (L) are present. Red blood 
cells may be present within the capillaries (Ca). There is 
no evidence of fluid accumulation or interstitial fibrosis, 
(x 3250).
Fig. 3.12: EM-Myocardium of control rat (120 days)
Transverse section through myofibers (Mf) of left 
ventricle show the presence of numerous mitochondria (M) in 
the sarcoplasm of the cells. Heterogeneous light-dark 
staining pattern of filaments was due to the direction of sec­
tioning through the striated areas of the fiber. Capillary 
(Ca), Nucleus (N), Sarcoplasmic Reticulum (SR). (x 8250).
Fig. 3.13: EM-Myocardium of ethanol-treated rat (120 days)
Note the filament orientation characteristic of 
transverse sections through the myofibers (Mf). The mito­
chondria (M) are abundant and do not show signs of 
degeneration. Intra-cellular spaces (arrow) in the sarco­
plasm (Sa) are probably due to fixation. Nucleus, (N)
(x 12,500) .
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reticulum associated with ethanol consumption were not 
generalized, as one or two swollen vesicles were seen within 
a cell in which the remainder of the reticulum was unaltered. 
Furthermore, these alterations in the elements of the 
sarcoplasmic reticulum were not strictly limited to the 
myocardium of the ethanol-treated groups.
The contractile elements of the myofibers in 
ethanol-treated rats showed no evidence of disorientation 
or fragmentation (Figs. 3.7, 3.8). Increases in the amount 
of connective tissue surrounding the vessels of the heart 
generally indicates interstitial fibrosis has occurred. No 
changes in these areas as a result of ethanol treatment, 
however, were observed in these studies with the electron 
microscope (Figs. 3.4, 3.5, 3.10, 3.11).
Similar studies of this nature showed that chronic 
ethanol treatment resulted in pronounced alterations of 
myocardial ultrastructure. The significance of the results 
obtained in this study in relation to the earlier studies 
will be discussed in Section 4.6.
3.7 Effect of Ethanol on Mitochondrial Protein Profiles
Electrophoresis of total mitochondrial proteins from 
the hearts of ethanol-treated rats show no apparent differ­
ences in gel pattern in comparison with corresponding 
controls after 60 and 120 days of treatment (Figs. 3.14, 
3.15). The qualitative results shown in Fig. 3.14 were 
verified quantitatively by comparison of the absorbance 
scans of the electrophoretic patterns observed for each 
sample (Fig. 3.15). The electrophoretic patterns observed 
were highly reproducible in eight replicate runs and also
patterns of total mitochondrial proteins from 
the hearts of ethanol-treated rats and their 
corresponding controls at 60 days and 120 days 
of treatment
Fig. 3.14-: Qualitative comparison of electrophoretic
Mitochondrial protein from the hearts of each 
experimental group was isolated and prepared for SDS poly­
acrylamide gel electrophoresis as described in Section 2.11. 
100 gg of protein from each sample was applied to gels and 
electrophoresis was performed at room temperature at 40V 
for 45 minutes and 200V for 2 hours. The gels were stained 
in Coomassie Brilliant Blue to resolve mitochondrial protein 
bands.
Comparison of the SDS Polyacrylamide Gel Electrophoretic 
Patterns of Total Mitochondrial Proteins from the Hearts 
of Ethanol-Treated and Control Rats at 60 and 120 Days
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Fig. 3.15: Quantitative comparison of electrophoretic
patterns of total mitochondrial proteins from 
the hearts of ethanol-treated rats and their 
corresponding controls at 60 days and 120 
days of treatment
Mitochondrial protein from the hearts of each experi­
mental group was Isolated and prepared for SDS polyacrylamide 
gel electrophoresis as described in Section 2.11. 100 yg of
protein from each sample was applied to gels and electro­
phoresis was performed at room temperature at 40V for 45 
minutes and 200V for 2 hours. The gels were stained in 
Coomassie Brilliant Blue to resolve mitochondrial protein 
bands. The absorbance scan for each sample was determined at 
600 nm and accompanied by a determination of peak areas. 
Further details of this quantitative method are given in 
Sect ion 2.12.2:
A: 60 Day ethanol-treated group
B: 60 Day control group
C: 120 Day ethanol-treated group
D: 120 Day control group
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showed that there were no changes in mitochondrial proteins 
between the two series, 60 and 120 days, of experimental 
animals. The results indicate that chronic ethanol consump­
tion has no discernible effect on the protein composition 
of mitochondria from the hearts of chronic ethanol-treated 
rats.
In order to determine the effects of chronic ethanol 
consumption of mitochondrial protein synthesis in vivo, 
ethanol-treated and control rats were injected intraperiton-
3eally with H-leucine. Mitochondria were isolated two 
hours after the injection as Beattie et al. (1970) showed
that maximal distribution of radioactive label throughout 
the mitochondria occurred at this time.
Approximately 90% of mitochondrial protein synthesis 
occurs in the cytoplasm and is then incorporated with the 
products of mitochondrial protein synthesis, which accounts 
for the remaining 10% of total mitochondrial protein. This 
study of total mitochondrial proteins, therefore, is con­
cerned with the effect of chronic ethanol consumption on
3the incorporation of H-leucine into proteins from both
3systems. Table 3.4 shows the H-leucine incorporation in 
vivo, into mitochondria from hearts of ethanol-treated and 
control rats at 60 and 120 days of treatment. A 20% increase
3in the incorporation of H-leucine into total mitochondrial 
protein is observed in mitochondria isolated from the 
hearts of rats treated with ethanol for 120 days.
A comparison of the electrophoretic patterns of 
labelled mitochondrial proteins from hearts of ethanol- 
treated rats and the corresponding controls determined by 
the gel slicing technique is shown in Fig. 3.16. There
Table 3.4: Incorporation in vivo of H-leueine into total
mitochondrial proteins of the hearts of 
ethanol-treated and control rats at 60 and 120 
days of treatment
3
3Rats were injected with 400 pCi H-leucine intra- 
peritoneally and after two hours the heart mitochondria 
were isolated and incorporation of the radioactive label 
was determined in acid precipitable protein as described in 
Section 2.10.2. Results are expressed as the counts 
min-l-mg-l Qf mitochondria protein. The mitochondrial 
protein from the hearts of 5 rats was used for each deter­
mination .
3Incorporation of H-Leucine 
Counts min ^-mg  ^ of mitochondrial protein
60 Day 
Control
60 Day 
Ethanol- 
Treated
120 Day 
Control
120 Day
Ethanol-
Treated
1016.0150.8 1012.0t50.6 1171.1158.6 1413.2170.6
Fig. 3.16: Comparison of SDS polyacrylamide gel electro
phoretic profiles of ^H-leucine labelled pro
teins synthesized in the mitochondria, of
hearts from ethanol-treated rats and the
corresponding controls at 60 and 120 days of
treatment
3Rats were injected with 400 yCi H-leucine intra- 
peritoneally and after two hours the mitochondria were 
isolated and prepared for electrophoresis as described in 
Sections 2.10.1 and 2.11. 100 gg samples of protein were
applied to SDS polyacrylamide gels and electrophoresed al 
40V for 45 minutes and 200V for approximately 2 hours. The 
gels were stained in Coomassie Blue to show the protein 
banding pattern charactertistic of the mitochondrial 
proteins. The protein pattern for each sample was cut into 
2.0 mm slices (Section 2.12.5) and the radioactivity of each 
slice was determined. Counts are expressed as disintegra­
tions min~l. The mitochondria from the hearts of 5 rats were 
used for each sample.
A: 60 days experimental groups - ethanol treated ----
control
B: 120 days experimental groups - ethanol treated----
control
Approximate Molecular Weight x 10
Distance Migrated (or,)
Approximate Molecular Weight x 10 0
Met M  I i '. IM  I • -.1 ( • "Ill)
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were differences in the radioactive profile of mitochond­
rial proteins synthesized after 60 days of treatment (Fig. 
3.16), but the changes that occurred were not significant.
At 120 days, however, radioactivity in the protein fraction 
corresponding to a molecular weight of approximately 45,000- 
50,000, was significantly increased in the ethanol group.
The increase in radioactivity of this particular protein 
fraction may in part be responsible for the modest increase
3in the incorporation of H-leucine into total mitochondrial 
proteins observed in the ethanol-treated rats at this time.
In light of the results that the heart mitochondria 
from rats in every experimental group have similar protein
3compositions, it is likely that an increase in H-leucine 
incorporation into total mitochondrial proteins after 120 
days of chronic ethanol intoxication is due to an increase 
in the protein turnover rates of a protein fraction 
corresponding to a molecular weight of 45,000-50,000.
It is not possible to determine the source or func­
tional nature of the protein fraction of molecular weight 
45,000-50,000 or what role it has in the mitochondria, from 
these experiments. These findings will be discussed in 
Section 4.7.
Autoradiography of gels containing radioactive 
electrophoretic patterns of the products of total mitochon­
drial protein synthesis failed to provide any better data 
than that obtained using the gel slicing technique and 
measurement of radioactivity in the sliced sections. The 
mitochondrial proteins labelled in vivo did not incorporate
3sufficient H-leucine to produce any photographic result
after an interval of six weeks.
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CHAPTER 4 
DISCUSSION
4.1 Importance of Diet in Studies of Alcoholic Cardio­
myopathy
The subject of whether alcohol, uncomplicated by 
dietary factors, can produce changes in cardiac function 
has been one of tremendous controversy, preceded only by 
the same problem in determining the etiological factor in 
alcoholic liver disease. Several diets have been designed 
to study these problems. These dietary regimens are in 
agreement only with regards to the quantity of ethanol that 
must be consumed, not only to produce pathological changes, 
but to simulate the human alcoholic consumption level. The 
amount of alcohol ingested must supply 35-40% of the total 
daily caloric intake (Lieber et al. , 1965; Porta and 
Gomez-Dumm, 1968; Regan et at. , 1975).
The most widely used methods for administering this 
amount of alcohol to laboratory animals include: (1) put­
ting alcohol (ethanol) in the drinking water, the solid 
diets being consumed separately (Porta and Gomez-Dumm, 1968; 
Segal et al. , 1975; Pachinger et al., 1973); (2) incor­
poration of ethanol into 'nutritionally adequate' liquid 
diets (Lieber et al., 1965); and (3) adding sucrose to the 
drinking water containing the ethanol to enhance consump­
tion (Porta and Gomez-Dumm). Isocaloric pair-feeding for 
all three methods has been accomplished by providing the 
control animals with sucrose or dextran-maltose as an 
ethanol caloric replacement (DeCarli and Lieber, 1967;
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Porta and Gomez-Dumm, Lieber et al. , 1965).
A diet of the first mode (1) was adopted for the 
study reported (Sec. 2.2). The belief that liquid diets 
are unnatural for rats (Porta and Gomez-Dumm, 1968) and the 
unsuitability of sucrose feeding for any purpose led to 
this decision (Madras et al. , 1973; Pennington et al. ,
1977; Abdulla et al., 1980). A 25% aqueous ethanol 
solution was administered to rats as their sole source of 
drinking fluid (Sec. 3.1). Table 3.1 shows that this con­
centration of ethanol provided approximately 40% of the 
total daily caloric intake of animals in the ethanol group. 
An initial adjustment period of one to two weeks was 
necessary, presumably to allow the rats to adjust to the 
effects and taste of alcohol. This was followed by a 
period of regular alcohol and food consumption (Fig. 3.1). 
Vitamin supplements used in similar studies had no pronounc­
ed protective properties against ethanol and were not 
included in this diet (Abe et al., 1979; Eriksson et al., 
1980; Dubroff et al., 1979; Segal et al., 1975).
The problem that remains with every dietary regimen 
designed to study the effects of prolonged ethanol intake 
is that despite isocaloric pair-feeding the rate of growth 
is less in animals receiving ethanol comprising 35-40% of 
total calories compared to the control animals (Porta and 
Gomez-Dumm, 1968; Lieber et al., 1965; Lieber, 1973).
This retarded growth is seen even when the total caloric 
intake of ethanol-treated animals exceeds that of the con­
trols (Antal et al. , 1979). Whether this growth impairment 
results from the 'empty' calories of ethanol due to 
inefficient substrate utilization (Lieber, 1973 and 1975)
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or impaired amino acid absorption (Banks et al., 1970) is 
now known.
For the maintenance of isocaloric controls in this 
study (described in the legend of Fig. 3.1) the mean weight 
of the ethanol-treated animals was used as the 'guide' for 
the management of the caloric allowance for the control 
group. This procedure was adopted to avoid the use of 
diets with any carbohydrate caloric boosters such as sucrose 
or dextran-maltose.
In summary, Table 3.1 and Fig. 3.1 show that in the 
dietary regimens of this study, the ethanol-treated rats 
received 40% of their calories as alcohol, and that after 
60 days of treatment, both experimental groups maintained 
similar weights indicating that both received equal 
quantities of 'useful' calories.
4.2 Maintenance of Moderate Levels of Blood Ethanol
In studies with chronic alcohol consumption, 
moderate levels of blood ethanol (75-200 mg-%) were neces­
sary to observe ethanol-induced pathological changes in the 
liver and heart (Regan et al., 1975). This level of blood 
ethanol corresponds with the amount of ethanol which must 
be consumed to provide 35-40% of total calories (DeCarli 
and Lieber, 1967). Blood ethanol levels in rats consuming 
a 25% aqueous ethanol solution were examined at 7, 35, 60,
90 and 120 days of treatment (Sec. 2.3). Moderate blood 
levels of ethanol were shown to exist (Fig. 3.2) throughout 
the study, reaching the highest level of 192 mg % after 35 
days of treatment. These results provide evidence in 
support of the direct caloric measurements (Table 3.1)
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which showed that throughout the time course of the study, 
the amount of alcohol ingested accounted for 35-40% of the 
total caloric intake. The results show that contrary to 
some conventional beliefs rats will ingest a high concentra­
tion of ethanol without reducing their intake below the 
desired quantity (Porta and Gomez-Dumm, 1968). The 
animals also showed a moderate growth rate during the time 
course (Fig. 3.1).
It is well known that tolerance to ethanol develops 
upon continued ingestion (Hawkins et al., 1966). Several 
factors may influence this ability of rats to tolerate 
ethanol, in part it reflects a decrease in the sensitivity 
of the central nervous system to ethanol and it is also 
conceivable that the difference in the distribution of 
ethanol in the body may play some role (Hawkins et al., 
1966). In addition, when rats are fed ethanol chronically 
a marked increase in their ability to oxidize ethanol has 
been observed (Tobin and Mezey, 1971; Thurman et al.,
1976; DeCarli and Lieber, 1967). This adaptive increase 
in ethanol metabolism has also been observed in some 
alcoholic humans (Mendelson, 1966; Kater et al., 1968) and 
may account for increased tolerance. Two adaptive changes 
might increase the rate of ethanol metabolism in chronically 
treated subjects, viz. an increase in the liver alcohol 
dehydrogenase activity and the microsomal ethanol oxidizing 
system, MHOS (Hawkins et al., 1966; Thurman et al., 1968; 
Lieber and DeCarli, 1968; Rubin et al. , 1970a)-
The studies reported here (Sec. 3.3 and Fig. 3.2) 
showed that a decreased level of blood ethanol (95 mg %) 
persisted throughout the final 30 days of the time course
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and support the concept that there was an increased metabo­
lism of ethanol during this final phase of treatment. A 
lower plasma level of circulating ethanol may be responsible 
for the adaptive changes in cardiac metabolism associated 
with chronic consumption (Lochner et al., 1969) and 
indicates that there is a direct toxic role for ethanol in 
the pathogenesis of alcoholic cardiomyopathy. Evidence 
that myocardial damage is reversible upon the complete 
removal of ethanol from the diet adds support to the theory 
that there is a toxic role for ethanol in the myocardium 
(Weishaar et al. , 1977).
4.3 Effects of Ethanol on Mitochondrial Respiratory 
Function
The deleterious effects of alcohol on mitochondrial 
function have been investigated and the findings generally 
support the concept that chronic ethanol consumption 
resulted in impaired functional integrity shown by respira­
tory inhibition in the mitochondria (Pachinger et al., 1973; 
Sarma et al., 1976; Segal et al., 1975; Alexander et al. , 
1977a; Shishov et al., 1977). Similar studies of mito­
chondrial respiratory function were conducted in this inves­
tigation of the pathogenesis of alcoholic cardiomyopathies 
(Sec. 2.7).
The respiratory control ratio (RCR), a sensitive 
criteria of biochemical integrity (Chance and Williams,
1956) and the maximum rate of Og consumption in the presence 
of ADP (QO^) were measured to ascertain the effect of 
chronic ethanol feeding on the heart mitochondria. Bearing 
in mind the importance of fatty acids as a cardiac energy
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source (Gilbertson, 1977; Fritz, 1961) and the findings 
that lipid accumulation results from ethanol treatment 
(Hibbs et al. , 1965; Ferrans et al. , 1965; Burch et al., 
1971; Alexander et al. , 1977b) fatty acids were featured 
as respiratory substrates for this study. Pyruvate was 
also included as a substrate (Sec. 2.7).
The results of these experiments (Table 3.2) show 
that a notable decline occurred in the RCR of mitochondria 
isolated from the hearts of ethanol-treated rats when com­
pared with the control values, when the substrate palmitoyl- 
CoA was employed. Why there was no measurable change in 
the RCR with palmitoy1-CoA as substrate at 120 days of 
treatment is not understood. It may be possible that an 
adaptive phenomenon occurs in the mitochondria by this 
time. Table 3.2 shows that when pyruvate was the substrate, 
the RCRs were uniformly depressed throughout the time 
course in the mitochondria from ethanol-treated rats when 
contrasted to control values. Statistical significance was 
not attached to these results, however. When the RCR of 
mitochondria from ethanol-treated rats were contrasted with 
RCR from normal rat heart mitochondria with palmitoyl- 
carnitine as substrate, a depression was noted after 120 
days in the ethanol group. As with the substrate pyruvate, 
statistical significance could not be attached to this 
finding.
Measurement of QC^ in the heart mitochondria of 
ethanol-treated and control rats (Table 3.2) showed that 
when these values were contrasted, there were various 
degrees of depression in QOg values of the ethanol group 
throughout the time course when pyruvate was the substrate.
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This was also true after 120 days of treatment when palmi- 
toylcarnitine was the substrate. The results showed, 
however, that for all substrates employed, statistical sig­
nificance could not be assigned to a decline in the maximum 
rate of consumption by rat heart mitochondria of 
ethanol-treated animals throughout the time course.
It may be concluded from this study that mitochon­
drial respiratory function is not affected to a significant 
degree by ethanol treatment. No predictable, specific 
pattern of change was revealed from this investigation of 
these parameters of RCR and QOg.
Similar studies by other workers (Pachinger et al., 
1973; Segal et al., 1975; Sarma et al., 1977; Alexander 
et al. , 1977a) reported more significant decreases in RCR 
and QC>2 values. Their data generally supports the sugges­
tion that chronic ethanol consumption results in a non­
specific overall respiratory inhibition of heart mitochon­
dria. In light of the results of this study it is not 
possible to confirm these suggestions. More data would 
need to be gathered for a longer period of treatment to 
attribute significance to these results.
4.4 Effects of Ethanol on Enzymes of Fatty Acid Oxidation
One of the outstanding changes in the heart 
tissue reported to occur as a result of chronic ethanol con 
sumption was the accumulation of triglyceride droplets in 
the muscle fibers (Hibbs et al., 1965; Ferrans et al., 
1965; Burch et al., 1971; Alexander et al., 1977a,b; 
Marciniak et al., 1967). It has been reported that ethanol 
treatment results in an increased incorporation of fatty
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acids into tissue triglycerides in the perfused heart (Lochner 
et al. , 1969; Regan et al. , 1974) and also diminished the 
rate of fatty acid oxidation (Lochner et al., 1969; Regan 
et al., 1974; Kikuchi and Kako, 1970). Since long chain 
fatty acids are a major fuel for the heart (Gilbertson,
1977; Fritz, 1961) it was suggested that a decrease in the 
rate of oxidation of fatty acids in the heart was linked to 
the accumulation of triglycerides (Lochner et al., 1969; 
Regan et al., 1974; Kikuchi and Kako, 1970; Williams and 
Ting-Kai, 1977).
Lesions at the level of mitochondrial fatty acid 
activation and transport or lesions in the ancillary 
enzymes of 3-oxidation may be responsible for the decrease 
in the rate of oxidation reported. To test this hypothesis, 
selected portions of the oxidative pathway of fatty acids 
(described in Sec. 2.8) were investigated in this study.
The results obtained (Table 3.3) in this study 
showed that there were decreases in the activities of the 
enzymes carnitine palmitoyl transferase, 3-hydroxyacy1-CoA 
dehydrogenase, and acetoacety1-CoA thiolase. These data 
suggest the possibility that there are multiple defects in 
fatty acid metabolism. The consequences of a possible 
insufficiency in the activity of each of the enzymes will 
be discussed with the aim of further elucidating an aspect 
of the mechanism of ethanol-induced conditions in the heart.
A de (' ici oncy i n 1 he ac t i vi t y o f ca rn i l i no 
palmitoyl transferase will clearly limit the availability 
of long chain fatty acids for oxidation in the mitochondrial 
matrix (see Fig. 1.2). The importance of this is best 
appreciated in light of the fact that the contribution of
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fatty acid oxidation to the total caloric requirement of 
muscle provides more than 50% of the energy (Bank et al. , 
1975). Glycogen also contributes an important source of 
energy for muscle contraction, during short periods of 
muscle exercise. Defective glycogen utilization due to 
enzyme abnormalities such as myophosphorylase deficiency 
(McArdle disease) or muscle phosphofructokinase deficiency 
(Tarui disease) are seen under the stress of short duration 
exercise to result in ATP depletion and muscle breakdown 
(Patten etal., 1979; Reza et al. , 1978; Bank et al. , 
1975). Similarly, defective lipid utilization due to a 
carnitine palmitoyl transferase deficiency has been des­
cribed in a rare myopathic condition and may have the same 
result to the above at times of prolonged exercise or stress 
when the demand for energy from the metabolism of lipids 
is great (Bank et al., 1975; Reza et al., 1978; Patten 
et al., 1979; Layzer et al., 1980). It has been shown 
that when the demand for energy exceeds the supply, muscle 
membrane integrity is seriously impaired, presumably due 
to a deficiency of ATP production (Rowland and Penn, 1972). 
This may lead to acute muscle necrosis. The results of 
myopathies characterized by carnitine palmitoyl transferase 
deficiency also include muscle weakness, acute respiratory 
failure and increased lipid storage (Patten et al., 1979; 
Reza et al., 1978; Bertorini et al., 1980; Hostetler et 
al. , 1978) .
It is clear that a deficiency in carnitine palmi­
toyl transferase activity could account for the pathogene­
sis of alcohol-induced cardiomyopathies, as described 
above. The condition, however, is a skeletal muscular
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disease in which 70-80% of the carnitine palmitoyl trans­
ferase activity is lost and probably has genetic origins 
(Herman and Nadler, 1977; Bank et al., 1975). The results 
(Table 3.3) obtained as a consequence of chronic ethanol 
ingestion show a decrease of 30% in the activity of this 
enzyme in heart which may indicate that other factors also 
contribute to the pathogenesis of alcoholic cardiomyopathy. 
One further factor in particular may have an effect on 
carnitine palmitoyl transferase activity in heart and 
should not be overlooked in a discussion of the impaired 
transport of fatty acids into mitochondria. The role of 
carnitine as a substrate for carnitine acyl transferase 
enzymes and its availability could impose considerable 
limitations on the transport mechanism.
This point can best be illustrated by again describ­
ing a rare myopathic condition this time resulting from 
severe carnitine deficiency in skeletal muscle tissues.
The syndrome of muscle carnitine deficiency involves muscle 
weakness and is reminiscent of alcoholic cardiomyopathies 
since the condition is associated with pathological lipid 
accumulation and abnormal mitochondria are also found 
(Isaacs et al., 1976; Engel et al., 1977; Almog et al., 
1979). In a similar fashion to alcoholic cardiomyopathy, 
there is a significant failure of the sarcoplasmic reticu­
lum to accumulate calcium (Isaacs et al., 1976).
The role of carnitine may go beyond that of long 
chain fatty acid transport, however, including such func­
tions as buffering and protecting the CoA pool, as well as 
branched chain fatty acid and amino acid metabolism (Brass 
and Hoppel, 1980). The carnitine-mediated transfer of acyl
groups out of mitochondria has been demonstrated but is of 
unknown physiological importance (Bremer and Wojtczak, 1972). 
Shunting of acyl groups (intermediates of oxidative metabol­
ism) from the intra-mitochondrial pool might affect rates 
of C>2 consumption and oxidative product formation (Brass 
and Hoppel, 1980).
Mitochondrial CoA itself has been suggested to have 
a regulatory function and any carnitine-induced changes in 
the CoA pool could have important metabolic consequences 
(Lee and Fritz, 1972). In relation to the findings of 
this particular study, it is possible that control of the 
enzyme acetoacety1-CoA thiolase, which shows a significant 
ethanol-induced decrease in activity (Table 3.3) may 
be affected by intramitochondrial concentrations of CoA.
Acetoacety1-CoA thiolase is the enzyme responsible 
for catalyzing the oxidation of ketone bodies to acetyl- 
CoA and serves as the final step for the conversion of 
long chain fatty acids to acetyl-CoA which is then oxidized 
to COg via the tricarboxylic acid cycle (Fong and Schulz, 
1978). Because of the critical positional role this 
enzyme plays in fatty acid oxidation, it is possible that 
several metabolic factors control its activity. In 
addition to the role of intra-mitochondrial CoA-SH concen­
trations as a possible controlling factor, acetyl-CoA con­
centration in the mitochondria may also exert a controlling 
effect on the activity of acctoacoty1-CoA thiolase (see 
Fig. 1.3). It is not possible, however, from these studies 
to determine what factors are responsible for the ethanol- 
induced decrease in activity of this enzyme.
Changes that occur early in the pathogenesis of
82 .
alcoholic cardiomyopathy may be reflected by the transient 
depression of 3-hydroxyacyl-CoA dehydrogenase activity at 
60 days of ethanol treatment (Table 3.3). This enzyme is 
the only enzyme studied that requires the pyridine nucleo­
tide cofactor NAD+. Since it is not understood why this 
enzyme undergoes a transient depression in activity, direct 
measurement of the redox state of the pyridine nucleotide 
ratio NAD/NADH in the heart should accompany future time 
course studies of chronic ethanol treatment.
Although a specific biochemical abnormality has not 
been identified in alcoholic cardiomyopathy, the emerging 
pattern suggests that several different enzymatic dis­
orders may be shown to affect fatty acid oxidation in 
cardiac muscle. Certainly changes in the enzymes of lipid 
metabolism could contribute to alterations in the lipid 
composition of the myocardium as a result of ethanol treat­
ment .
4.5 Ethanol-Induced Ultrastructural Changes in Rat 
Myocardium
Histochemical, light microscope, and electron micro­
scope studies have linked heart disease with chronic 
alcoholism, suggesting that the consumption of alcohol 
results in structural alterations in the myocardium leading 
to heart failure. The main purpose of the present study 
was to determine whether in rats alcohol can produce myo­
cardial damage and if so to elucidate the types of alter­
ations and their sequence of appearance during a period of 
chronic consumption of ethanol.
The results of this study (Sec. 3.5) show that the
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myocardium of ethanol-treated rats which were subjected to 
the same tissue preparation as the control animals did not 
exhibit significant ultrastructural changes associated 
with chronic ethanol consumption. The pathological changes 
which were observed in the myocardium from ethanol-treated 
rats were marginal in comparison to the control rats. The 
observations which led to this conclusion are discussed 
with respect to various structural elements of cardiac 
muscle.
Swelling of the sarcoplasmic reticulum is a report­
ed finding in long term experimental studies on alcohol 
toxicity (Alexander et al., 1977b; Burch et al., 1971; 
Rossi, 1980; Segal et al., 1975). While certain areas of 
the myocardium of alcohol-fed rats appeared to have promin­
ent sarcoplasmic vessicles, they were not significantly 
different from those observed in the tissue of control 
animals. This apparent change in ultrastructure of the 
sarcoplasmic reticulum observed for both experimental 
groups is most likely an artifact of fixation. It is im­
portant that any comparative ultrastructural study is 
carefully evaluated in terms of tissue preparation, includ­
ing fixation, dehydration, and embedding procedures.
Despite great care in the perfusion fixation of hearts in 
this study uniform fixation was not obtained as evidenced 
by the presence of red blood cells within many of the 
vessels (Figs. 3.4, 3.5, 3.10, 3.11).
One of the most obvious changes in cardiac morphol­
ogy previously reported in experimental studies of 
alcoholic cardiomyopathy involves the mitochondria. An
increase in the number and size of mitochondria as well as
alterations in their shape and degeneration of the cristae 
have been observed with the electron microscope (Rossi,
1980; Burch et al. , 1971; Segal et al., 1975; Alexander 
et al. , 1977b).
Mitochondria are among the most conspicuous and 
characteristic cell organelles in muscle tissue. Although 
electron microscope studies give a static picture of mito­
chondrial structure and distribution, they are capable of 
altering their shape and position rapidly (Miledi and 
Slater, 1968). Furthermore, features of their distribution 
are highly dependent on the direction of sectioning. For 
these reasons, and because dramatic changes in the distribu­
tion and structure of mitochondria were not observed in 
this study, it was concluded that the mitochondria were not 
significantly affected by ethanol treatment up to 120 days. 
It was not within the scope of this study to investigate 
the quantity of tissue samples necessary, nor to employ 
quantitative methods necessary for assessing marginal 
changes in mitochondrial structure or numbers which may 
have occurred after 120 days of ethanol treatment.
Lipid droplets and lipofuscin pigment deposits 
have been seen in normal human cardiac muscle. In small 
animals, such as the rat, lipid droplets are plentiful 
throughout the interfibri1lar sarcoplasm (Bloom and Faucett, 
1968). An increase in lipid deposition may occur in res­
ponse' l.o chronic, ethanol treatment, in experimental animals 
(Vasdev et al., 1975; Burch et al., 1971). However, there 
is some evidence that lipid accumulation is not a response 
to chronic ethanol treatment in laboratory animals (Segal 
et al., 1975; Hall and Rowlands, 1970; Rossi, 1980).
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Changes in lipid distribution or quantity in rat 
cardiac tissue were not observed in this study, throughout 
the time course of ethanol treatment. To state that lipid 
deposition was increased in the course of chronic ethanol 
consumption, as in the case with a quantitative assessment 
of mitochondrial changes, requires tremendous numbers of 
samples, as well as a reliable method of making quantitat­
ive measurements. An equally important factor to consider 
is the relative instability of triglyceride deposition due 
to its role as a metabolic reserve. Triglyceride content 
of muscle is not static and changes with variations in the 
metabolic demand of the animal (Padykula and Gauthier,
1963). Similar problems are encountered in an attempt to 
demonstrate quantitative changes in the metabolic reserves 
of glycogen.
A change in the fatty acid composition of the lipid 
droplets was apparent in the 120 day ethanol-treated rats 
(Fig. 3.8). This change was observed as an increase in 
the proportion of opaque lipid droplets characteristic of 
saturated fatty acids in the tissue of ethanol-treated 
rats when compared to the tissue of control rats which 
showed dark, osmiophilic lipid droplets characteristic of 
unsaturated fatty acids. Prolonged dehydration of tissues 
during preparation may 'leech out' the dark staining 
osmium of unsaturated lipids resulting in a similar opaque 
appearance of the droplets, however, this is an unlikely 
explanation,for all tissues were dehydrated according to 
identical schedules.
Another prominent feature of ultrastructural changes 
associated with experimental alcoholic cardiomyopathy is
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disorientation and fragmentation of the myofilaments 
(Segal et al. , 1975; Burch et al. , 1971; Rossi, 1980; 
Alexander et al., 1977). This was not an observation in 
this study as the myofibrils showed no evidence of fibrosis 
or loss of striation (Figs. 3.7, 3.9).
Upon examination of different samples from each 
heart it became obvious that the morphology of the myocar­
dial cells differed greatly from one area to another. 
Although this study was restricted to the left ventricle, 
this variability requires a study of a great number of 
blocks of tissue from each heart of several (6-10) animals 
from each group to determine the nature and degree of 
pathologic changes. Indeed a reliable technique for 
measuring quantitative changes was also needed. Although 
it was beyond the scope of this investigation to carry out 
such a rigorous and wide-embracing examination, the present 
study does indicate that no obvious ultrastructural changes 
in rat myocardium result during a period (120 days) of 
ethanol consumption. These results do not support the con­
cept that alcohol is directly toxic to the heart (Burch et 
al., 1971; Segel et al., 1975; Alexander et al., 1977b) 
and suggest in agreement with Hall and Rowlands (1970) an 
indirect etiological significance of alcohol in myocardial 
injury.
4.6 Effects of Ethanol on Total Mitochondrial Proteins
The possibility that mitochondrial dysfunction is 
partly responsible for myocardial failure' associated with 
chronic ethanol consumption has been suggested (Bing, 1978).
The isolated mitochondria have been described as defective
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with respect to respiratory control (Pachinger et al. ,
1973; Segal et al., 1975; Shishob et al., 1977, Sarma et 
al. , 1976; Williams and Ting-Kai, 1977), calcium 
accumulation (Bing, 1978), oxidative enzymes (Wendt et al., 
1965; Pachinger et al., 1973; Williams and Ting-Kai,
1977) and ultrastructure (Hibbs et al. , 1965; Alexander 
et al., 1977b; Burch et al., 1971; Segal et al. , 1975).
By means of biochemical analysis, it should be possible to 
ultimately identify specific changes in the mitochondrial 
protein composition which lead to the more pronounced 
functional and structural impairment reported in the liter­
ature .
The results of such analysis reported in this study 
(Sec. 3.6) showed that the protein composition of mito­
chondria isolated from the hearts of ethanol-treated rats 
was similar to that of the control rats throughout the 
time course (Figs. 3.14, 3.15). Despite the similarity in 
overall protein composition, however, incorporation of
3H-leucine in vivo into total mitochondrial proteins from 
the hearts of rats treated with ethanol for 120 days when 
contrasted with the controls was increased by 20% (Table 
3.4). An increase in synthesis of a protein fraction with 
a molecular weight of 45,000-50,000 which was not present 
in the mitochondrial profile of the control group, may be 
responsible for this increase (Fig. 3.16). Because the 
overall mitochondrial protein composition was unchanged at 
this time (Figs. 3.14, 3.15) it is likely that the increase
3in ‘II-.leucine incorporation was due to an increase in the 
relative rate of protein turnover of proteins in this 
fraction. The relevance of the three distinct peaks in the
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protein synthetic profile of mitochondria in the ethanol- 
treated group at 60 days was not understood. These changes 
were not significant and may have been due to the gel 
slicing technique used (Sec. 2.12.5) in this study.
It was not apparent from this experiment (Sec. 3.6) 
whether the slight changes in protein synthesis which 
occurred at 60 days of ethanol treatment and the more sig­
nificant change at 120 days of ethanol treatment were due 
to enzyme proteins or structural proteins of the mitochon­
dria. However, the results of the comparative studies on 
the enzymes of lipid oxidation (Sec. 3.4) showed signific­
ant changes in the activities of three enzymes throughout 
the 120 day time course as a result of ethanol treatment.
The pathological studies (Sec. 3.5) moreover, showed that 
the ultrastructure of the heart mitochondria appeared 
normal throughout the time course in ethanol-treated 
animals. From this limited data, it appears that these 
alterations in the synthesis of mitochondrial proteins 
(Fig. 3.16) which resulted from ethanol treatment were due 
to proteins of the enzyme fraction of mitochondria. These 
experiments indicated that changes in the protein composit­
ion of mitochondria could occur as a result of ethanol 
treatment before more pronounced alterations in mitochond­
rial respiratory function and ultrastructure were evident.
4.7 Concluding Remarks
Reports in the literature have indicated that mito­
chondrial dysfunction, including impaired respiration 
(Pachinger et al., 1973; Segal et at., 1975; Sarma et al., 
1976; Bing, 1978) and calcium sequestration may be related
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to cardiac failure in alcoholic cardiomyopathy (Bing, 1978). 
The changes noted in mitochondrial function were not sur­
prising in the light of the destruction wrought by ethanol 
on their ultrastructure (llibbs et al. , 1965; Alexander, 
1966, 1977b; Burch et at., 1976; Segal et at., 1975). 
Concomitant with ethanol-induced mitochondrial dysfunction 
was the suggestion that impaired fatty acid oxidation was 
responsible for the pronounced increase in myocardial 
triglyceride deposition in patients with alcoholic cardio­
myopathy (Lochner et at., 1969; Kikuchi and Kako, 1970).
Based on these suggestions, the effect of chronic 
alcohol consumption for 60 and 120 days on the mitochondrial 
respiratory integrity, enzymes of fatty acid oxidation and 
ultrastructure of heart muscle was examined using the rat 
as an experimental model. In addition, analytical studies 
on the mitochondrial protein composition were initiated.
Significant changes occurred in the activities of 
several enzymes of fatty acid oxidation (Sec. 3.4) without 
concomitant significant changes in mitochondrial respiratory 
functions (Sec. 3.3). It was not surprising, in the light 
of functionally adequate mitochondria to find that their 
ultrastructure was unaltered (Sec. 3.5).
Within the scope of the ultrastructural investiga­
tion (Sec. 3.5) undertaken in this investigation, it was 
not possible to state that myocardial triglyceride content 
was increased by ethanol treatment in the rat. There was, 
however, evidence for alterations in lipid metabolism shown 
by changes in the fatty acid composition of the triglycer­
ide droplets deposited in the myocardium. The changes 
observed in fatty acid composition may be related to the
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effect of ethanol on the enzymes of fatty acid oxidation.
Studies on mitochondrial protein composition (Sec. 
3.6) showed that ethanol had an effect on mitochondrial 
protein synthesis, especially after 120 days of treatment. 
An increase in protein synthesis at this time associated 
with a protein fraction with a molecular weight of 45,000- 
50,000 may indicate an increased rale of turnover of these 
proteins in response to ethanol. An increased turnover 
rate of this fraction may be a compensatory response by 
several enzymes in the heart mitochondria either to the 
direct effects of ethanol or to metabolic changes induced 
by ethanol in the heart. Much work, however, is needed in 
this area before any firm conclusions can be made.
Finally, because this investigation did not show 
significant changes in mitochondrial respiratory function 
and ultrastructure in the rat heart, does not indicate 
that the rat is an unsuitable experimental model for 
studying alcoholic cardiomyopathy. Before drawing any 
conclusion, these studies with rats should be carried out 
over a longer period of alcohol administration.
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